{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T18:17:15Z","timestamp":1793297835588,"version":"4.5.0"},"reference-count":234,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T00:00:00Z","timestamp":1762473600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T00:00:00Z","timestamp":1762473600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82072668"],"award-info":[{"award-number":["82072668"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biomed"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Gastrointestinal (GI) malignancies represent a significant global health burden, characterized by high mortality rates and profound resistance to conventional therapies. This necessitates the exploration of novel therapeutic vulnerabilities, and two recently discovered forms of regulated cell death, ferroptosis and cuproptosis, offer promising metabolism-centered strategies. Ferroptosis is a non-apoptotic pathway driven by iron-dependent lipid peroxidation, canonically suppressed by the glutathione peroxidase 4 (GPX4) axis. In contrast, cuproptosis is a distinct process wherein excess copper induces lethal proteotoxic stress through direct binding to lipoylated components of the tricarboxylic acid (TCA) cycle. Critically, these pathways are not mutually exclusive; instead, they are intricately connected through shared molecular nodes and metabolic dependencies, including redox homeostasis, key signaling proteins, and mitochondrial integrity. This review systematically examines the molecular crosstalk between ferroptosis and cuproptosis, highlighting the synergistic potential of their co-activation as a powerful anti-cancer strategy in GI tumors. We systematically evaluate both preclinical evidence and clinical studies for therapeutic interventions, ranging from small-molecule inducers to advanced nanoplatforms and immunotherapy combinations. Furthermore, we discuss the pressing challenges of identifying predictive biomarkers for patient stratification and overcoming adaptive resistance. Ultimately, deciphering the ferroptosis-cuproptosis nexus holds immense potential to unlock a new paradigm of synergistic therapies, paving the way for more effective clinical management of GI malignancies.<\/jats:p>","DOI":"10.1186\/s43556-025-00347-7","type":"journal-article","created":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T07:39:44Z","timestamp":1762501184000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Targeting ferroptosis and cuproptosis in gastrointestinal cancers: molecular mechanisms, metabolic vulnerabilities, and therapeutic interventions"],"prefix":"10.1186","volume":"6","author":[{"given":"Yang","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yixiang","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linhua","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-4178-8730","authenticated-orcid":false,"given":"Hui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,7]]},"reference":[{"issue":"8","key":"347_CR1","doi-asserted-by":"publisher","first-page":"656","DOI":"10.20892\/j.issn.2095-3941.2024.0145","volume":"21","author":"Y Teng","year":"2024","unstructured":"Teng Y, Xia C, Cao M, Yang F, Yan X, He S, et al. Esophageal cancer global burden profiles, trends, and contributors. Cancer Biol Med. 2024;21(8):656\u201366. https:\/\/doi.org\/10.20892\/j.issn.2095-3941.2024.0145.","journal-title":"Cancer Biol Med"},{"issue":"8","key":"347_CR2","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1016\/j.cgh.2024.02.023","volume":"22","author":"DT M\u00fclder","year":"2024","unstructured":"M\u00fclder DT, Hahn AI, Huang RJ, Zhou MJ, Blake B, Omofuma O, et al. Prevalence of gastric precursor lesions in countries with differential gastric cancer burden: a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2024;22(8):1605-17.e46. https:\/\/doi.org\/10.1016\/j.cgh.2024.02.023.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"9","key":"347_CR3","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1016\/j.cgh.2024.12.027","volume":"23","author":"F Boekstegers","year":"2025","unstructured":"Boekstegers F, Ponce CB, Morales E, Mu\u00f1oz-Castro C, Lindner C, Lira IS, et al. Gallbladder cancer and dysplasia in cholecystectomy specimens: a large study in high-incidence regions of South America. Clin Gastroenterol Hepatol. 2025;23(9):1535-45.e7. https:\/\/doi.org\/10.1016\/j.cgh.2024.12.027.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"7","key":"347_CR4","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1002\/cac2.70017","volume":"45","author":"M Li","year":"2025","unstructured":"Li M, Cao S, Xu RH. Global trends and epidemiological shifts in gastrointestinal cancers: insights from the past four decades. Cancer Commun. 2025;45(7):774\u201388. https:\/\/doi.org\/10.1002\/cac2.70017.","journal-title":"Cancer Commun"},{"issue":"4","key":"347_CR5","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1053\/j.gastro.2023.12.022","volume":"166","author":"YC Chen","year":"2024","unstructured":"Chen YC, Malfertheiner P, Yu HT, Kuo CL, Chang YY, Meng FT, et al. Global prevalence of Helicobacter pylori infection and incidence of gastric cancer between 1980 and 2022. Gastroenterology. 2024;166(4):605\u201319. https:\/\/doi.org\/10.1053\/j.gastro.2023.12.022.","journal-title":"Gastroenterology"},{"issue":"5","key":"347_CR6","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/j.jhep.2024.10.031","volume":"82","author":"EY Tan","year":"2025","unstructured":"Tan EY, Danpanichkul P, Yong JN, Yu Z, Tan DJH, Lim WH, et al. Liver cancer in 2021: global burden of disease study. J Hepatol. 2025;82(5):851\u201360. https:\/\/doi.org\/10.1016\/j.jhep.2024.10.031.","journal-title":"J Hepatol"},{"issue":"4","key":"347_CR7","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1097\/js9.0000000000001054","volume":"110","author":"Z Li","year":"2024","unstructured":"Li Z, Zhang X, Sun C, Li Z, Fei H, Zhao D. Global, regional, and national burdens of early onset pancreatic cancer in adolescents and adults aged 15\u201349 years from 1990 to 2019 based on the Global Burden of Disease Study 2019: a cross-sectional study. Int J Surg. 2024;110(4):1929\u201340. https:\/\/doi.org\/10.1097\/js9.0000000000001054.","journal-title":"Int J Surg"},{"issue":"4","key":"347_CR8","doi-asserted-by":"publisher","first-page":"756","DOI":"10.3350\/cmh.2024.0318","volume":"30","author":"D Kim","year":"2024","unstructured":"Kim D, Manikat R, Wijarnpreecha K, Cholankeril G, Ahmed A. Burden of mortality from hepatocellular carcinoma and biliary tract cancers by race and ethnicity and sex in US, 2018\u20132023. Clin Mol Hepatol. 2024;30(4):756\u201370. https:\/\/doi.org\/10.3350\/cmh.2024.0318.","journal-title":"Clin Mol Hepatol"},{"issue":"6","key":"347_CR9","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.14309\/ajg.0000000000003198","volume":"120","author":"Y Huang","year":"2024","unstructured":"Huang Y, Huang H, Wei T, Zhang A, Zhang H, Zhang Z, et al. Disparities, trends, and predictions to 2040 in gastrointestinal cancer incidence, mortality in the United States. Am J Gastroenterol. 2024;120(6):1367\u201380. https:\/\/doi.org\/10.14309\/ajg.0000000000003198.","journal-title":"Am J Gastroenterol"},{"issue":"12","key":"347_CR10","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1038\/s41575-024-00967-4","volume":"21","author":"LY Mak","year":"2024","unstructured":"Mak LY, Liu K, Chirapongsathorn S, Yew KC, Tamaki N, Rajaram RB, et al. Liver diseases and hepatocellular carcinoma in the Asia-Pacific region: burden, trends, challenges and future directions. Nat Rev Gastroenterol Hepatol. 2024;21(12):834\u201351. https:\/\/doi.org\/10.1038\/s41575-024-00967-4.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"11","key":"347_CR11","doi-asserted-by":"publisher","first-page":"e2445525","DOI":"10.1001\/jamanetworkopen.2024.45525","volume":"7","author":"S Qiu","year":"2024","unstructured":"Qiu S, Cai J, Yang Z, He X, Xing Z, Zu J, et al. Trends in hepatocellular carcinoma mortality rates in the US and projections through 2040. JAMA Netw Open. 2024;7(11):e2445525. https:\/\/doi.org\/10.1001\/jamanetworkopen.2024.45525.","journal-title":"JAMA Netw Open"},{"issue":"1","key":"347_CR12","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s43556-024-00239-2","volume":"6","author":"Y Gu","year":"2025","unstructured":"Gu Y, Yang R, Zhang Y, Guo M, Takehiro K, Zhan M, et al. Molecular mechanisms and therapeutic strategies in overcoming chemotherapy resistance in cancer. Mol Biomed. 2025;6(1):2. https:\/\/doi.org\/10.1186\/s43556-024-00239-2.","journal-title":"Mol Biomed"},{"issue":"26","key":"347_CR13","doi-asserted-by":"publisher","first-page":"2509","DOI":"10.1056\/NEJMoa1500596","volume":"372","author":"DT Le","year":"2015","unstructured":"Le DT, Uram JN, Wang H, Bartlett BR, Kemberling H, Eyring AD, et al. PD-1 blockade in tumors with mismatch-repair deficiency. N Engl J Med. 2015;372(26):2509\u201320. https:\/\/doi.org\/10.1056\/NEJMoa1500596.","journal-title":"N Engl J Med"},{"key":"347_CR14","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s13578-020-00456-6","volume":"10","author":"D Xia","year":"2020","unstructured":"Xia D, Zhang X-R, Ma Y-L, Zhao Z-J, Zhao R, Wang Y-Y. Nrf2 promotes esophageal squamous cell carcinoma (ESCC) resistance to radiotherapy through the CaMKII\u03b1-associated activation of autophagy. Cell Biosci. 2020;10:90. https:\/\/doi.org\/10.1186\/s13578-020-00456-6.","journal-title":"Cell Biosci"},{"key":"347_CR15","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1016\/j.bioactmat.2025.06.052","volume":"52","author":"Z Zhang","year":"2025","unstructured":"Zhang Z, Wu Y, Liu Y, Zhang J, Zhang Y, Dai Y, et al. From mechanism to application: programmed cell death pathways in nanomedicine-driven cancer therapies. Bioact Mater. 2025;52:773\u2013809. https:\/\/doi.org\/10.1016\/j.bioactmat.2025.06.052.","journal-title":"Bioact Mater"},{"issue":"9","key":"347_CR16","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1038\/s41573-023-00749-8","volume":"22","author":"K Hadian","year":"2023","unstructured":"Hadian K, Stockwell BR. The therapeutic potential of targeting regulated non-apoptotic cell death. Nat Rev Drug Discov. 2023;22(9):723\u201342. https:\/\/doi.org\/10.1038\/s41573-023-00749-8.","journal-title":"Nat Rev Drug Discov"},{"issue":"1","key":"347_CR17","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1186\/s12964-023-01267-1","volume":"21","author":"Y Li","year":"2023","unstructured":"Li Y, Du Y, Zhou Y, Chen Q, Luo Z, Ren Y, et al. Iron and copper: critical executioners of ferroptosis, cuproptosis and other forms of cell death. Cell Commun Signal. 2023;21(1):327. https:\/\/doi.org\/10.1186\/s12964-023-01267-1.","journal-title":"Cell Commun Signal"},{"issue":"5","key":"347_CR18","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","volume":"149","author":"SJ Dixon","year":"2012","unstructured":"Dixon SJ, Lemberg KM, Lamprecht MR, Skouta R, Zaitsev EM, Gleason CE, et al. Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell. 2012;149(5):1060\u201372. https:\/\/doi.org\/10.1016\/j.cell.2012.03.042.","journal-title":"Cell"},{"issue":"1\u20132","key":"347_CR19","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.cell.2013.12.010","volume":"156","author":"WS Yang","year":"2014","unstructured":"Yang WS, SriRamaratnam R, Welsch ME, Shimada K, Skouta R, Viswanathan VS, et al. Regulation of ferroptotic cancer cell death by GPX4. Cell. 2014;156(1\u20132):317\u201331. https:\/\/doi.org\/10.1016\/j.cell.2013.12.010.","journal-title":"Cell"},{"issue":"7784","key":"347_CR20","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1038\/s41586-019-1705-2","volume":"575","author":"K Bersuker","year":"2019","unstructured":"Bersuker K, Hendricks JM, Li Z, Magtanong L, Ford B, Tang PH, et al. The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit ferroptosis. Nature. 2019;575(7784):688\u201392. https:\/\/doi.org\/10.1038\/s41586-019-1705-2.","journal-title":"Nature"},{"issue":"6586","key":"347_CR21","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1126\/science.abf0529","volume":"375","author":"P Tsvetkov","year":"2022","unstructured":"Tsvetkov P, Coy S, Petrova B, Dreishpoon M, Verma A, Abdusamad M, et al. Copper induces cell death by targeting lipoylated TCA cycle proteins. Science. 2022;375(6586):1254\u201361. https:\/\/doi.org\/10.1126\/science.abf0529.","journal-title":"Science"},{"issue":"10","key":"347_CR22","doi-asserted-by":"publisher","first-page":"1786","DOI":"10.1016\/j.molcel.2022.05.001","volume":"82","author":"PA Cobine","year":"2022","unstructured":"Cobine PA, Brady DC. Cuproptosis: Cellular and molecular mechanisms underlying copper-induced cell death. Mol Cell. 2022;82(10):1786\u20137. https:\/\/doi.org\/10.1016\/j.molcel.2022.05.001.","journal-title":"Mol Cell"},{"issue":"1","key":"347_CR23","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s12943-024-01977-1","volume":"23","author":"S Yang","year":"2024","unstructured":"Yang S, Hu C, Chen X, Tang Y, Li J, Yang H, et al. Crosstalk between metabolism and cell death in tumorigenesis. Mol Cancer. 2024;23(1):71. https:\/\/doi.org\/10.1186\/s12943-024-01977-1.","journal-title":"Mol Cancer"},{"issue":"6","key":"347_CR24","doi-asserted-by":"publisher","first-page":"101678","DOI":"10.1016\/j.gendis.2025.101678","volume":"12","author":"L Wang","year":"2025","unstructured":"Wang L, Zhu Y, Huang C, Pan Q, Wang J, Li H, et al. Targeting ferroptosis in cancer stem cells: a novel strategy to improve cancer treatment. Genes Dis. 2025;12(6):101678. https:\/\/doi.org\/10.1016\/j.gendis.2025.101678.","journal-title":"Genes Dis"},{"key":"347_CR25","doi-asserted-by":"publisher","first-page":"116115","DOI":"10.1016\/j.biopha.2023.116115","volume":"171","author":"N Liu","year":"2024","unstructured":"Liu N, Chen M. Crosstalk between ferroptosis and cuproptosis: from mechanism to potential clinical application. Biomed Pharmacother. 2024;171:116115. https:\/\/doi.org\/10.1016\/j.biopha.2023.116115.","journal-title":"Biomed Pharmacother"},{"key":"347_CR26","doi-asserted-by":"publisher","unstructured":"Wang J, Li J, Liu J, Chan KY, Lee HS, Lin KN et al. Interplay of ferroptosis and cuproptosis in cancer: dissecting metal-driven mechanisms for therapeutic potentials. Cancers (Basel). 2024;16(3). https:\/\/doi.org\/10.3390\/cancers16030512.","DOI":"10.3390\/cancers16030512"},{"issue":"Pt 1","key":"347_CR27","doi-asserted-by":"publisher","first-page":"138100","DOI":"10.1016\/j.jcis.2025.138100","volume":"699","author":"J Xu","year":"2025","unstructured":"Xu J, Wang Y, Williams GR, Zheng Y, Zhang Y, Wang T, et al. A photothermally triggered cascade bioreactor for cuproptosis and ferroptosis-driven cancer immunotherapy. J Colloid Interface Sci. 2025;699(Pt 1):138100. https:\/\/doi.org\/10.1016\/j.jcis.2025.138100.","journal-title":"J Colloid Interface Sci"},{"issue":"3","key":"347_CR28","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.tcb.2015.10.014","volume":"26","author":"WS Yang","year":"2016","unstructured":"Yang WS, Stockwell BR. Ferroptosis: death by lipid peroxidation. Trends Cell Biol. 2016;26(3):165\u201376. https:\/\/doi.org\/10.1016\/j.tcb.2015.10.014.","journal-title":"Trends Cell Biol"},{"issue":"6","key":"347_CR29","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1016\/j.cmet.2020.10.011","volume":"32","author":"J Zheng","year":"2020","unstructured":"Zheng J, Conrad M. The metabolic underpinnings of ferroptosis. Cell Metab. 2020;32(6):920\u201337. https:\/\/doi.org\/10.1016\/j.cmet.2020.10.011.","journal-title":"Cell Metab"},{"issue":"9","key":"347_CR30","doi-asserted-by":"publisher","first-page":"2054","DOI":"10.1080\/15548627.2020.1810918","volume":"17","author":"X Chen","year":"2021","unstructured":"Chen X, Li J, Kang R, Klionsky DJ, Tang D. Ferroptosis: machinery and regulation. Autophagy. 2021;17(9):2054\u201381. https:\/\/doi.org\/10.1080\/15548627.2020.1810918.","journal-title":"Autophagy"},{"issue":"12","key":"347_CR31","doi-asserted-by":"publisher","first-page":"2215","DOI":"10.1016\/j.molcel.2022.03.022","volume":"82","author":"D Liang","year":"2022","unstructured":"Liang D, Minikes AM, Jiang X. Ferroptosis at the intersection of lipid metabolism and cellular signaling. Mol Cell. 2022;82(12):2215\u201327. https:\/\/doi.org\/10.1016\/j.molcel.2022.03.022.","journal-title":"Mol Cell"},{"issue":"1","key":"347_CR32","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/nchembio.2239","volume":"13","author":"S Doll","year":"2017","unstructured":"Doll S, Proneth B, Tyurina YY, Panzilius E, Kobayashi S, Ingold I, et al. ACSL4 dictates ferroptosis sensitivity by shaping cellular lipid composition. Nat Chem Biol. 2017;13(1):91\u20138. https:\/\/doi.org\/10.1038\/nchembio.2239.","journal-title":"Nat Chem Biol"},{"key":"347_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2017.09.044","author":"SE Wenzel","year":"2017","unstructured":"Wenzel SE, Tyurina YY, Zhao J, St Croix CM, Dar HH, Mao G, et al. PEBP1 wardens ferroptosis by enabling lipoxygenase generation of lipid death signals. Cell. 2017. https:\/\/doi.org\/10.1016\/j.cell.2017.09.044.","journal-title":"Cell"},{"issue":"9","key":"347_CR34","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1038\/cr.2016.95","volume":"26","author":"M Gao","year":"2016","unstructured":"Gao M, Monian P, Pan Q, Zhang W, Xiang J, Jiang X. Ferroptosis is an autophagic cell death process. Cell Res. 2016;26(9):1021\u201332. https:\/\/doi.org\/10.1038\/cr.2016.95.","journal-title":"Cell Res"},{"issue":"1","key":"347_CR35","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.canlet.2015.07.031","volume":"368","author":"M-Z Ma","year":"2015","unstructured":"Ma M-Z, Chen G, Wang P, Lu W-H, Zhu C-F, Song M, et al. Xc- inhibitor sulfasalazine sensitizes colorectal cancer to cisplatin by a GSH-dependent mechanism. Cancer Lett. 2015;368(1):88\u201396. https:\/\/doi.org\/10.1016\/j.canlet.2015.07.031.","journal-title":"Cancer Lett"},{"key":"347_CR36","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.freeradbiomed.2024.06.006","volume":"222","author":"H Li","year":"2024","unstructured":"Li H, Li Y, Yu Y, Ren X, Yang C, Jin W, et al. GSH exhaustion via inhibition of xCT-GSH-GPX4 pathway synergistically enhanced DSF\/Cu-induced cuproptosis in myelodysplastic syndromes. Free Radic Biol Med. 2024;222:130\u201348. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2024.06.006.","journal-title":"Free Radic Biol Med"},{"issue":"3","key":"347_CR37","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.cell.2017.11.048","volume":"172","author":"I Ingold","year":"2018","unstructured":"Ingold I, Berndt C, Schmitt S, Doll S, Poschmann G, Buday K, et al. Selenium utilization by GPX4 is required to prevent hydroperoxide-induced ferroptosis. Cell. 2018;172(3):409-22.e21. https:\/\/doi.org\/10.1016\/j.cell.2017.11.048.","journal-title":"Cell"},{"issue":"2","key":"347_CR38","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1152\/physrev.00031.2024","volume":"105","author":"J Zheng","year":"2025","unstructured":"Zheng J, Conrad M. Ferroptosis: when metabolism meets cell death. Physiol Rev. 2025;105(2):651\u2013706. https:\/\/doi.org\/10.1152\/physrev.00031.2024.","journal-title":"Physiol Rev"},{"issue":"7784","key":"347_CR39","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1038\/s41586-019-1707-0","volume":"575","author":"S Doll","year":"2019","unstructured":"Doll S, Freitas FP, Shah R, Aldrovandi M, da Silva MC, Ingold I, et al. FSP1 is a glutathione-independent ferroptosis suppressor. Nature. 2019;575(7784):693\u20138. https:\/\/doi.org\/10.1038\/s41586-019-1707-0.","journal-title":"Nature"},{"issue":"1","key":"347_CR40","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1021\/acscentsci.9b01063","volume":"6","author":"VAN Kraft","year":"2020","unstructured":"Kraft VAN, Bezjian CT, Pfeiffer S, Ringelstetter L, M\u00fcller C, Zandkarimi F, et al. GTP cyclohydrolase 1\/tetrahydrobiopterin counteract ferroptosis through lipid remodeling. ACS Cent Sci. 2020;6(1):41\u201353. https:\/\/doi.org\/10.1021\/acscentsci.9b01063.","journal-title":"ACS Cent Sci"},{"issue":"8","key":"347_CR41","doi-asserted-by":"publisher","first-page":"e70244","DOI":"10.1002\/mco2.70244","volume":"6","author":"S Malla","year":"2025","unstructured":"Malla S, Neupane R, Sood S, Hussein N, Abou-Dahech M, Terrero D, et al. Mitochondria as regulators of nonapoptotic cell death in cancer. MedComm. 2025;6(8):e70244. https:\/\/doi.org\/10.1002\/mco2.70244.","journal-title":"MedComm"},{"issue":"6","key":"347_CR42","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1038\/s41580-024-00703-5","volume":"25","author":"SJ Dixon","year":"2024","unstructured":"Dixon SJ, Olzmann JA. The cell biology of ferroptosis. Nat Rev Mol Cell Biol. 2024;25(6):424\u201342. https:\/\/doi.org\/10.1038\/s41580-024-00703-5.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"4","key":"347_CR43","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1038\/s41419-024-06691-w","volume":"15","author":"QY Zhou","year":"2024","unstructured":"Zhou QY, Ren C, Li JY, Wang L, Duan Y, Yao RQ, et al. The crosstalk between mitochondrial quality control and metal-dependent cell death. Cell Death Dis. 2024;15(4):299. https:\/\/doi.org\/10.1038\/s41419-024-06691-w.","journal-title":"Cell Death Dis"},{"issue":"5","key":"347_CR44","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1016\/j.immuni.2024.03.019","volume":"57","author":"HN Bell","year":"2024","unstructured":"Bell HN, Stockwell BR, Zou W. Ironing out the role of ferroptosis in immunity. Immunity. 2024;57(5):941\u201356. https:\/\/doi.org\/10.1016\/j.immuni.2024.03.019.","journal-title":"Immunity"},{"issue":"8","key":"347_CR45","doi-asserted-by":"publisher","first-page":"e70295","DOI":"10.1002\/mco2.70295","volume":"6","author":"M Jiang","year":"2025","unstructured":"Jiang M, Zhang K, Zhang Z, Zeng X, Huang Z, Qin P, et al. PI3K\/AKT\/mTOR axis in cancer: from pathogenesis to treatment. MedComm. 2025;6(8):e70295. https:\/\/doi.org\/10.1002\/mco2.70295.","journal-title":"MedComm"},{"issue":"37","key":"347_CR46","doi-asserted-by":"publisher","first-page":"eabm9427","DOI":"10.1126\/sciadv.abm9427","volume":"8","author":"KM Fujihara","year":"2022","unstructured":"Fujihara KM, Zhang BZ, Jackson TD, Ogunkola MO, Nijagal B, Milne JV, et al. Eprenetapopt triggers ferroptosis, inhibits NFS1 cysteine desulfurase, and synergizes with serine and glycine dietary restriction. Sci Adv. 2022;8(37):eabm9427. https:\/\/doi.org\/10.1126\/sciadv.abm9427.","journal-title":"Sci Adv"},{"issue":"10","key":"347_CR47","doi-asserted-by":"publisher","first-page":"2621","DOI":"10.1080\/15548627.2023.2218764","volume":"19","author":"Y Xie","year":"2023","unstructured":"Xie Y, Kang R, Klionsky DJ, Tang D. GPX4 in cell death, autophagy, and disease. Autophagy. 2023;19(10):2621\u201338. https:\/\/doi.org\/10.1080\/15548627.2023.2218764.","journal-title":"Autophagy"},{"issue":"7860","key":"347_CR48","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1038\/s41586-021-03539-7","volume":"593","author":"C Mao","year":"2021","unstructured":"Mao C, Liu X, Zhang Y, Lei G, Yan Y, Lee H, et al. DHODH-mediated ferroptosis defence is a targetable vulnerability in cancer. Nature. 2021;593(7860):586\u201390. https:\/\/doi.org\/10.1038\/s41586-021-03539-7.","journal-title":"Nature"},{"issue":"7","key":"347_CR49","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1016\/j.ccell.2025.05.008","volume":"43","author":"J Hu","year":"2025","unstructured":"Hu J, Jiang X. When essential metal elements become culprits-Cuproptosis in focus. Cancer Cell. 2025;43(7):1181\u20135. https:\/\/doi.org\/10.1016\/j.ccell.2025.05.008.","journal-title":"Cancer Cell"},{"issue":"8","key":"347_CR50","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1038\/s41423-022-00866-1","volume":"19","author":"Y Wang","year":"2022","unstructured":"Wang Y, Zhang L, Zhou F. Cuproptosis: a new form of programmed cell death. Cell Mol Immunol. 2022;19(8):867\u20138. https:\/\/doi.org\/10.1038\/s41423-022-00866-1.","journal-title":"Cell Mol Immunol"},{"issue":"20","key":"347_CR51","doi-asserted-by":"publisher","first-page":"19581","DOI":"10.1021\/acsnano.3c07775","volume":"17","author":"W Wang","year":"2023","unstructured":"Wang W, Mo W, Hang Z, Huang Y, Yi H, Sun Z, et al. Cuproptosis: harnessing transition metal for cancer therapy. ACS Nano. 2023;17(20):19581\u201399. https:\/\/doi.org\/10.1021\/acsnano.3c07775.","journal-title":"ACS Nano"},{"issue":"1","key":"347_CR52","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1038\/s41392-022-01229-y","volume":"7","author":"L Chen","year":"2022","unstructured":"Chen L, Min J, Wang F. Copper homeostasis and cuproptosis in health and disease. Signal Transduct Target Ther. 2022;7(1):378. https:\/\/doi.org\/10.1038\/s41392-022-01229-y.","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"347_CR53","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s12943-023-01732-y","volume":"22","author":"J Xie","year":"2023","unstructured":"Xie J, Yang Y, Gao Y, He J. Cuproptosis: mechanisms and links with cancers. Mol Cancer. 2023;22(1):46. https:\/\/doi.org\/10.1186\/s12943-023-01732-y.","journal-title":"Mol Cancer"},{"issue":"8","key":"347_CR54","doi-asserted-by":"publisher","first-page":"2175","DOI":"10.1080\/15548627.2023.2200554","volume":"19","author":"Q Xue","year":"2023","unstructured":"Xue Q, Kang R, Klionsky DJ, Tang D, Liu J, Chen X. Copper metabolism in cell death and autophagy. Autophagy. 2023;19(8):2175\u201395. https:\/\/doi.org\/10.1080\/15548627.2023.2200554.","journal-title":"Autophagy"},{"key":"347_CR55","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16213691","author":"M Ma\u0142yszko","year":"2024","unstructured":"Ma\u0142yszko M, Przyby\u0142kowski A. Copper and colorectal cancer. Cancers (Basel). 2024. https:\/\/doi.org\/10.3390\/cancers16213691.","journal-title":"Cancers (Basel)"},{"issue":"2","key":"347_CR56","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1038\/s41589-022-01159-4","volume":"19","author":"V Schulz","year":"2023","unstructured":"Schulz V, Basu S, Freibert SA, Webert H, Boss L, M\u00fchlenhoff U, et al. Functional spectrum and specificity of mitochondrial ferredoxins FDX1 and FDX2. Nat Chem Biol. 2023;19(2):206\u201317. https:\/\/doi.org\/10.1038\/s41589-022-01159-4.","journal-title":"Nat Chem Biol"},{"issue":"13","key":"347_CR57","doi-asserted-by":"publisher","first-page":"6282","DOI":"10.1039\/d5cs00083a","volume":"54","author":"L Mao","year":"2025","unstructured":"Mao L, Lu J, Wen X, Song Z, Sun C, Zhao Y, et al. Cuproptosis: mechanisms and nanotherapeutic strategies in cancer and beyond. Chem Soc Rev. 2025;54(13):6282\u2013334. https:\/\/doi.org\/10.1039\/d5cs00083a.","journal-title":"Chem Soc Rev"},{"issue":"5","key":"347_CR58","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1016\/j.ccell.2025.02.015","volume":"43","author":"Z Yang","year":"2025","unstructured":"Yang Z, Su W, Wei X, Pan Y, Xing M, Niu L, et al. Hypoxia inducible factor-1\u03b1 drives cancer resistance to cuproptosis. Cancer Cell. 2025;43(5):937-54.e9. https:\/\/doi.org\/10.1016\/j.ccell.2025.02.015.","journal-title":"Cancer Cell"},{"issue":"1","key":"347_CR59","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1186\/s13046-022-02485-0","volume":"41","author":"P Zheng","year":"2022","unstructured":"Zheng P, Zhou C, Lu L, Liu B, Ding Y. Elesclomol: a copper ionophore targeting mitochondrial metabolism for cancer therapy. J Exp Clin Cancer Res. 2022;41(1):271. https:\/\/doi.org\/10.1186\/s13046-022-02485-0.","journal-title":"J Exp Clin Cancer Res"},{"issue":"5","key":"347_CR60","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1038\/s41571-024-00876-0","volume":"21","author":"D Tang","year":"2024","unstructured":"Tang D, Kroemer G, Kang R. Targeting cuproplasia and cuproptosis in cancer. Nat Rev Clin Oncol. 2024;21(5):370\u201388. https:\/\/doi.org\/10.1038\/s41571-024-00876-0.","journal-title":"Nat Rev Clin Oncol"},{"key":"347_CR61","doi-asserted-by":"publisher","first-page":"122701","DOI":"10.1016\/j.biomaterials.2024.122701","volume":"311","author":"L Huang","year":"2024","unstructured":"Huang L, Zhu J, Wu G, Xiong W, Feng J, Yan C, et al. A strategy of \u201cadding fuel to the flames\u201d enables a self-accelerating cycle of ferroptosis-cuproptosis for potent antitumor therapy. Biomaterials. 2024;311:122701. https:\/\/doi.org\/10.1016\/j.biomaterials.2024.122701.","journal-title":"Biomaterials"},{"key":"347_CR62","doi-asserted-by":"publisher","first-page":"123688","DOI":"10.1016\/j.lfs.2025.123688","volume":"374","author":"X Wang","year":"2025","unstructured":"Wang X, Liu Z, Lin C. Metal ions-induced programmed cell death: how does oxidative stress regulate cell death? Life Sci. 2025;374:123688. https:\/\/doi.org\/10.1016\/j.lfs.2025.123688.","journal-title":"Life Sci"},{"issue":"1","key":"347_CR63","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s13045-024-01589-8","volume":"17","author":"C Zhang","year":"2024","unstructured":"Zhang C, Huang T, Li L. Targeting cuproptosis for cancer therapy: mechanistic insights and clinical perspectives. J Hematol Oncol. 2024;17(1):68. https:\/\/doi.org\/10.1186\/s13045-024-01589-8.","journal-title":"J Hematol Oncol"},{"key":"347_CR64","doi-asserted-by":"publisher","first-page":"1029092","DOI":"10.3389\/fimmu.2022.1029092","volume":"13","author":"Y Shen","year":"2022","unstructured":"Shen Y, Li D, Liang Q, Yang M, Pan Y, Li H. Cross-talk between cuproptosis and ferroptosis regulators defines the tumor microenvironment for the prediction of prognosis and therapies in lung adenocarcinoma. Front Immunol. 2022;13:1029092. https:\/\/doi.org\/10.3389\/fimmu.2022.1029092.","journal-title":"Front Immunol"},{"issue":"15","key":"347_CR65","doi-asserted-by":"publisher","first-page":"eadk3201","DOI":"10.1126\/sciadv.adk3201","volume":"10","author":"K Chen","year":"2024","unstructured":"Chen K, Zhou A, Zhou X, He J, Xu Y, Ning X. Cellular trojan horse initiates bimetallic Fe-Cu MOF-mediated synergistic cuproptosis and ferroptosis against malignancies. Sci Adv. 2024;10(15):eadk3201. https:\/\/doi.org\/10.1126\/sciadv.adk3201.","journal-title":"Sci Adv"},{"issue":"15","key":"347_CR66","doi-asserted-by":"publisher","first-page":"16284","DOI":"10.1021\/acs.jmedchem.5c01174","volume":"68","author":"QH Shen","year":"2025","unstructured":"Shen QH, Yu LB, Yao SM, Li ZY, Zhang QQ, Wang P, et al. Bioinspired construction of Cu-Fe bimetallic multienzyme mimetics as co-inducers of cuproptosis and ferroptosis. J Med Chem. 2025;68(15):16284\u201398. https:\/\/doi.org\/10.1021\/acs.jmedchem.5c01174.","journal-title":"J Med Chem"},{"key":"347_CR67","doi-asserted-by":"publisher","unstructured":"Wang P, Yu LB, Shen QH, Dao J, Di ZY, Li ZY et al. Synergistic Copper-Coordination\/Glutathione Reduction Drives an In Situ Type II-to-Type I Photodynamic Switch in Iridium-Based Photosensitizer Nanocomposites for Potentiated Cancer Immunotherapy. Adv Mater. 2025:e06349. https:\/\/doi.org\/10.1002\/adma.202506349.","DOI":"10.1002\/adma.202506349"},{"key":"347_CR68","doi-asserted-by":"publisher","first-page":"116727","DOI":"10.1016\/j.biopha.2024.116727","volume":"175","author":"Y Gao","year":"2024","unstructured":"Gao Y, Jin F, Zhang P, Zheng C, Zheng X, Xie J, et al. Elesclomol-copper synergizes with imidazole ketone erastin by promoting cuproptosis and ferroptosis in myelodysplastic syndromes. Biomed Pharmacother. 2024;175:116727. https:\/\/doi.org\/10.1016\/j.biopha.2024.116727.","journal-title":"Biomed Pharmacother"},{"issue":"2","key":"347_CR69","doi-asserted-by":"publisher","first-page":"403","DOI":"10.3324\/haematol.2020.259531","volume":"107","author":"R Birsen","year":"2022","unstructured":"Birsen R, Larrue C, Decroocq J, Johnson N, Guiraud N, Gotanegre M, et al. APR-246 induces early cell death by ferroptosis in acute myeloid leukemia. Haematologica. 2022;107(2):403\u201316. https:\/\/doi.org\/10.3324\/haematol.2020.259531.","journal-title":"Haematologica"},{"key":"347_CR70","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.mito.2023.05.003","volume":"71","author":"S Prasad Panda","year":"2023","unstructured":"Prasad Panda S, Kesharwani A. Micronutrients\/miRs\/ATP networking in mitochondria: Clinical intervention with ferroptosis, cuproptosis, and calcium burden. Mitochondrion. 2023;71:1\u201316. https:\/\/doi.org\/10.1016\/j.mito.2023.05.003.","journal-title":"Mitochondrion"},{"key":"347_CR71","doi-asserted-by":"publisher","first-page":"103795","DOI":"10.1016\/j.redox.2025.103795","volume":"86","author":"S Chen","year":"2025","unstructured":"Chen S, Chen T, Xu C, Yu X, Shi J, Yang C, et al. Iron overload exaggerates renal ischemia-reperfusion injury by promoting tubular cuproptosis via interrupting function of LIAS. Redox Biol. 2025;86:103795. https:\/\/doi.org\/10.1016\/j.redox.2025.103795.","journal-title":"Redox Biol"},{"key":"347_CR72","doi-asserted-by":"publisher","DOI":"10.1016\/j.jare.2024.10.026","author":"X Wang","year":"2024","unstructured":"Wang X, Yang J, Yang W, Sheng H, Jia B, Cheng P, et al. Multiple roles of p53 in cancer development: Regulation of tumor microenvironment, m(6)A modification and diverse cell death mechanisms. J Adv Res. 2024. https:\/\/doi.org\/10.1016\/j.jare.2024.10.026.","journal-title":"J Adv Res"},{"issue":"8","key":"347_CR73","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1038\/s41580-025-00842-3","volume":"26","author":"Y Liu","year":"2025","unstructured":"Liu Y, Stockwell BR, Jiang X, Gu W. P53-regulated non-apoptotic cell death pathways and their relevance in cancer and other diseases. Nat Rev Mol Cell Biol. 2025;26(8):600\u201314. https:\/\/doi.org\/10.1038\/s41580-025-00842-3.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"1","key":"347_CR74","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1186\/s12943-025-02337-3","volume":"24","author":"S Bhowmick","year":"2025","unstructured":"Bhowmick S, Banerjee S, Shridhar V, Mondal S. Reprogrammed immuno-metabolic environment of cancer: the driving force of ferroptosis resistance. Mol Cancer. 2025;24(1):161. https:\/\/doi.org\/10.1186\/s12943-025-02337-3.","journal-title":"Mol Cancer"},{"issue":"7545","key":"347_CR75","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nature14344","volume":"520","author":"L Jiang","year":"2015","unstructured":"Jiang L, Kon N, Li T, Wang S-J, Su T, Hibshoosh H, et al. Ferroptosis as a p53-mediated activity during tumour suppression. Nature. 2015;520(7545):57\u201362. https:\/\/doi.org\/10.1038\/nature14344.","journal-title":"Nature"},{"issue":"4","key":"347_CR76","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1038\/s41418-020-00728-1","volume":"28","author":"X Chen","year":"2021","unstructured":"Chen X, Yu C, Kang R, Kroemer G, Tang D. Cellular degradation systems in ferroptosis. Cell Death Differ. 2021;28(4):1135\u201348. https:\/\/doi.org\/10.1038\/s41418-020-00728-1.","journal-title":"Cell Death Differ"},{"issue":"1","key":"347_CR77","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1186\/s12943-024-02130-8","volume":"23","author":"X Zhang","year":"2024","unstructured":"Zhang X, Tang B, Luo J, Yang Y, Weng Q, Fang S, et al. Cuproptosis, ferroptosis and PANoptosis in tumor immune microenvironment remodeling and immunotherapy: culprits or new hope. Mol Cancer. 2024;23(1):255. https:\/\/doi.org\/10.1186\/s12943-024-02130-8.","journal-title":"Mol Cancer"},{"key":"347_CR78","doi-asserted-by":"publisher","DOI":"10.1089\/ars.2023.0007","author":"R Chen","year":"2023","unstructured":"Chen R, Zou J, Kang R, Tang D. The redox protein HMGB1 in cell death and cancer. Antioxid Redox Signal. 2023. https:\/\/doi.org\/10.1089\/ars.2023.0007.","journal-title":"Antioxid Redox Signal"},{"issue":"7","key":"347_CR79","doi-asserted-by":"publisher","first-page":"2737","DOI":"10.7150\/thno.106999","volume":"15","author":"S Wu","year":"2025","unstructured":"Wu S, Wang Q, Du J, Meng Q, Li Y, Miao Y, et al. A p-n heterojunction sonosensitizer for improved sono-immunotherapy via induction of multimodal cell death mechanisms. Theranostics. 2025;15(7):2737\u201356. https:\/\/doi.org\/10.7150\/thno.106999.","journal-title":"Theranostics"},{"issue":"1","key":"347_CR80","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1038\/s41392-022-01046-3","volume":"7","author":"W Gao","year":"2022","unstructured":"Gao W, Wang X, Zhou Y, Wang X, Yu Y. Autophagy, ferroptosis, pyroptosis, and necroptosis in tumor immunotherapy. Signal Transduct Target Ther. 2022;7(1):196. https:\/\/doi.org\/10.1038\/s41392-022-01046-3.","journal-title":"Signal Transduct Target Ther"},{"issue":"3","key":"347_CR81","doi-asserted-by":"publisher","first-page":"20240275","DOI":"10.1002\/exp.20240275","volume":"5","author":"Y Zhang","year":"2025","unstructured":"Zhang Y, Ya S, Huang J, Ju Y, Fang X, Ouyang X, et al. Spatial isolation of single Copper(I) sites for cascade enzyme-like catalysis and simultaneous ferroptosis\/cuproptosis boosted immunotherapy. Exploration. 2025;5(3):20240275. https:\/\/doi.org\/10.1002\/exp.20240275.","journal-title":"Exploration"},{"issue":"5\u20136","key":"347_CR82","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1007\/s10495-023-01927-0","volume":"29","author":"J Gu","year":"2024","unstructured":"Gu J, Guo C, Ruan J, Li K, Zhou Y, Gong X, et al. From ferroptosis to cuproptosis, and calcicoptosis, to find more novel metals-mediated distinct form of regulated cell death. Apoptosis. 2024;29(5\u20136):586\u2013604. https:\/\/doi.org\/10.1007\/s10495-023-01927-0.","journal-title":"Apoptosis"},{"key":"347_CR83","doi-asserted-by":"publisher","unstructured":"Gieleci\u0144ska A, Kciuk M, Kontek R. The impact of calcium overload on cellular processes: exploring calcicoptosis and its therapeutic potential in cancer. Int J Mol Sci. 2024;25(24). https:\/\/doi.org\/10.3390\/ijms252413727.","DOI":"10.3390\/ijms252413727"},{"key":"347_CR84","doi-asserted-by":"publisher","first-page":"116040","DOI":"10.1016\/j.ejmech.2023.116040","volume":"265","author":"R Li","year":"2024","unstructured":"Li R, Wu Y, Li Y, Shuai W, Wang A, Zhu Y, et al. Targeted regulated cell death with small molecule compounds in colorectal cancer: current perspectives of targeted therapy and molecular mechanisms. Eur J Med Chem. 2024;265:116040. https:\/\/doi.org\/10.1016\/j.ejmech.2023.116040.","journal-title":"Eur J Med Chem"},{"issue":"1","key":"347_CR85","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/s12967-025-06121-1","volume":"23","author":"Y Cong","year":"2025","unstructured":"Cong Y, Li N, Zhang Z, Shang Y, Zhao H. Cuproptosis: molecular mechanisms, cancer prognosis, and therapeutic applications. J Transl Med. 2025;23(1):104. https:\/\/doi.org\/10.1186\/s12967-025-06121-1.","journal-title":"J Transl Med"},{"issue":"2","key":"347_CR86","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.cell.2017.09.021","volume":"171","author":"BR Stockwell","year":"2017","unstructured":"Stockwell BR, Friedmann Angeli JP, Bayir H, Bush AI, Conrad M, Dixon SJ, et al. Ferroptosis: a regulated cell death nexus linking metabolism, redox biology, and disease. Cell. 2017;171(2):273\u201385. https:\/\/doi.org\/10.1016\/j.cell.2017.09.021.","journal-title":"Cell"},{"issue":"5","key":"347_CR87","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1002\/cac2.70001","volume":"45","author":"K Lu","year":"2025","unstructured":"Lu K, Wijaya CS, Yao Q, Jin H, Feng L. Cuproplasia and cuproptosis, two sides of the coin. Cancer Commun. 2025;45(5):505\u201324. https:\/\/doi.org\/10.1002\/cac2.70001.","journal-title":"Cancer Commun"},{"key":"347_CR88","doi-asserted-by":"publisher","DOI":"10.1016\/j.actbio.2025.07.067","author":"Y Liu","year":"2025","unstructured":"Liu Y, Cai X, Liu J, Luo Z, Zhang J, Cao Z, et al. The role of redox homeostasis in tumor progression: implications for cancer therapy. Acta Biomater. 2025. https:\/\/doi.org\/10.1016\/j.actbio.2025.07.067.","journal-title":"Acta Biomater"},{"issue":"12","key":"347_CR89","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1016\/j.tcb.2023.04.005","volume":"33","author":"AF Dos Santos","year":"2023","unstructured":"Dos Santos AF, Fazeli G, Xavier da Silva TN, Friedmann Angeli JP. Ferroptosis: mechanisms and implications for cancer development and therapy response. Trends Cell Biol. 2023;33(12):1062\u201376. https:\/\/doi.org\/10.1016\/j.tcb.2023.04.005.","journal-title":"Trends Cell Biol"},{"key":"347_CR90","doi-asserted-by":"publisher","unstructured":"Begolli R, Patouna A, Vardakas P, Xagara A, Apostolou K, Kouretas D et al. Deciphering the landscape of GATA-mediated transcriptional regulation in gastric cancer. Antioxidants (Basel). 2024;13(10). https:\/\/doi.org\/10.3390\/antiox13101267.","DOI":"10.3390\/antiox13101267"},{"issue":"1","key":"347_CR91","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s12935-024-03262-z","volume":"24","author":"ZH Geng","year":"2024","unstructured":"Geng ZH, Du JX, Chen YD, Fu PY, Zhou PH, Qin WZ, et al. YY1: a key regulator inhibits gastric cancer ferroptosis and mediating apatinib-resistance. Cancer Cell Int. 2024;24(1):71. https:\/\/doi.org\/10.1186\/s12935-024-03262-z.","journal-title":"Cancer Cell Int"},{"issue":"1","key":"347_CR92","doi-asserted-by":"publisher","first-page":"6523","DOI":"10.1038\/s41467-023-42025-8","volume":"14","author":"L Sun","year":"2023","unstructured":"Sun L, Zhang Y, Yang B, Sun S, Zhang P, Luo Z, et al. Lactylation of METTL16 promotes cuproptosis via m(6)a-modification on FDX1 mRNA in gastric cancer. Nat Commun. 2023;14(1):6523. https:\/\/doi.org\/10.1038\/s41467-023-42025-8.","journal-title":"Nat Commun"},{"key":"347_CR93","doi-asserted-by":"publisher","first-page":"155220","DOI":"10.1016\/j.phymed.2023.155220","volume":"123","author":"W Huang","year":"2024","unstructured":"Huang W, Wen F, Yang P, Li Y, Li Q, Shu P. Yi-qi-hua-yu-jie-du decoction induces ferroptosis in cisplatin-resistant gastric cancer via the AKT\/GSK3\u03b2\/NRF2\/GPX4 axis. Phytomedicine. 2024;123:155220. https:\/\/doi.org\/10.1016\/j.phymed.2023.155220.","journal-title":"Phytomedicine"},{"key":"347_CR94","doi-asserted-by":"publisher","first-page":"111368","DOI":"10.1016\/j.cbi.2024.111368","volume":"407","author":"Y Fu","year":"2025","unstructured":"Fu Y, Huang G, Cai Y, Ren M, Cheng R, Chai Y, et al. Integrated network pharmacology, bioinformatics, and experiment analysis to decipher the molecular mechanism of Salidroside on Gastric cancer via targeting NCOA4-mediated ferritinophagy. Chem Biol Interact. 2025;407:111368. https:\/\/doi.org\/10.1016\/j.cbi.2024.111368.","journal-title":"Chem Biol Interact"},{"issue":"1","key":"347_CR95","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s10565-024-09931-z","volume":"40","author":"C Wu","year":"2024","unstructured":"Wu C, Wang S, Huang T, Xi X, Xu L, Wang J, et al. NPR1 promotes cisplatin resistance by inhibiting PARL-mediated mitophagy-dependent ferroptosis in gastric cancer. Cell Biol Toxicol. 2024;40(1):93. https:\/\/doi.org\/10.1007\/s10565-024-09931-z.","journal-title":"Cell Biol Toxicol"},{"issue":"21","key":"347_CR96","doi-asserted-by":"publisher","first-page":"e2415983","DOI":"10.1002\/advs.202415983","volume":"12","author":"Y Zhou","year":"2025","unstructured":"Zhou Y, Dong C, Shen X, Wang P, Chen T, Li W, et al. Targeting PTBP3-mediated alternative splicing of COX11 induces cuproptosis for inhibiting gastric cancer peritoneal metastasis. Adv Sci. 2025;12(21):e2415983. https:\/\/doi.org\/10.1002\/advs.202415983.","journal-title":"Adv Sci"},{"issue":"1","key":"347_CR97","doi-asserted-by":"publisher","first-page":"28934","DOI":"10.1038\/s41598-025-14342-z","volume":"15","author":"B Ke","year":"2025","unstructured":"Ke B, Jin P, Wang XJ, Zhang RP, Liu N, Ma G. Pan-cancer landscape of ITGAV and its potential role in gastric cancer. Sci Rep. 2025;15(1):28934. https:\/\/doi.org\/10.1038\/s41598-025-14342-z.","journal-title":"Sci Rep"},{"issue":"1","key":"347_CR98","doi-asserted-by":"publisher","first-page":"3605","DOI":"10.1038\/s41467-025-58992-z","volume":"16","author":"Z Zhao","year":"2025","unstructured":"Zhao Z, He J, Qiu S, Wang L, Huangfu S, Hu Y, et al. Targeting PLK1-CBX8-GPX4 axis overcomes BRAF\/EGFR inhibitor resistance in BRAFV600E colorectal cancer via ferroptosis. Nat Commun. 2025;16(1):3605. https:\/\/doi.org\/10.1038\/s41467-025-58992-z.","journal-title":"Nat Commun"},{"issue":"6","key":"347_CR99","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1158\/0008-5472.Can-24-0275","volume":"84","author":"R Zhang","year":"2024","unstructured":"Zhang R, Kang R, Tang D. Gut microbiome mediates ferroptosis resistance for colorectal cancer development. Cancer Res. 2024;84(6):796\u20137. https:\/\/doi.org\/10.1158\/0008-5472.Can-24-0275.","journal-title":"Cancer Res"},{"key":"347_CR100","doi-asserted-by":"publisher","unstructured":"Targeting LGR4-Wnt activates ferroptosis and reverses drug resistance in colorectal cancer. Nat Cancer. 2024;5(4):542\u20133. https:\/\/doi.org\/10.1038\/s43018-023-00714-9.","DOI":"10.1038\/s43018-023-00714-9"},{"issue":"5","key":"347_CR101","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.1039\/d4fo04790g","volume":"16","author":"Y Chen","year":"2025","unstructured":"Chen Y, Zhang Y, Dai M, Qiu C, Sun Q, Fan T, et al. \u03b3-linolenic acid derived from Lactobacillus plantarum MM89 induces ferroptosis in colorectal cancer. Food Funct. 2025;16(5):1760\u201371. https:\/\/doi.org\/10.1039\/d4fo04790g.","journal-title":"Food Funct"},{"issue":"38","key":"347_CR102","doi-asserted-by":"publisher","first-page":"e2402795","DOI":"10.1002\/advs.202402795","volume":"11","author":"Y Di","year":"2024","unstructured":"Di Y, Zhang X, Wen X, Qin J, Ye L, Wang Y, et al. MAPK signaling-mediated RFNG phosphorylation and nuclear translocation restrain oxaliplatin-induced apoptosis and ferroptosis. Adv Sci. 2024;11(38):e2402795. https:\/\/doi.org\/10.1002\/advs.202402795.","journal-title":"Adv Sci"},{"issue":"1","key":"347_CR103","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1038\/s41419-025-07498-z","volume":"16","author":"J Deng","year":"2025","unstructured":"Deng J, Li Y, Yin L, Liu S, Li Y, Liao W, et al. Histone lactylation enhances GCLC expression and thus promotes chemoresistance of colorectal cancer stem cells through inhibiting ferroptosis. Cell Death Dis. 2025;16(1):193. https:\/\/doi.org\/10.1038\/s41419-025-07498-z.","journal-title":"Cell Death Dis"},{"key":"347_CR104","doi-asserted-by":"publisher","first-page":"103118","DOI":"10.1016\/j.redox.2024.103118","volume":"71","author":"J Liu","year":"2024","unstructured":"Liu J, Lu X, Zeng S, Fu R, Wang X, Luo L, et al. ATF3-CBS signaling axis coordinates ferroptosis and tumorigenesis in colorectal cancer. Redox Biol. 2024;71:103118. https:\/\/doi.org\/10.1016\/j.redox.2024.103118.","journal-title":"Redox Biol"},{"key":"347_CR105","doi-asserted-by":"publisher","first-page":"103722","DOI":"10.1016\/j.redox.2025.103722","volume":"85","author":"J Ma","year":"2025","unstructured":"Ma J, Zhang Y, Sun Z, Guo H, Li X, Cai J, et al. LncRNA PVT1 promotes cuproptosis through transcriptional activation of FDX1 in colorectal cancer. Redox Biol. 2025;85:103722. https:\/\/doi.org\/10.1016\/j.redox.2025.103722.","journal-title":"Redox Biol"},{"issue":"11","key":"347_CR106","doi-asserted-by":"publisher","first-page":"13481","DOI":"10.1021\/acsami.3c16813","volume":"16","author":"X Lin","year":"2024","unstructured":"Lin X, Chen H, Deng T, Cai B, Xia Y, Xie L, et al. Improved immune response for colorectal cancer therapy triggered by multifunctional nanocomposites with self-amplifying antitumor ferroptosis. ACS Appl Mater Interfaces. 2024;16(11):13481\u201395. https:\/\/doi.org\/10.1021\/acsami.3c16813.","journal-title":"ACS Appl Mater Interfaces"},{"key":"347_CR107","doi-asserted-by":"publisher","first-page":"1410603","DOI":"10.3389\/fimmu.2024.1410603","volume":"15","author":"C Wang","year":"2024","unstructured":"Wang C, Yang G, Feng G, Deng C, Zhang Q, Chen S. Developing an advanced diagnostic model for hepatocellular carcinoma through multi-omics integration leveraging diverse cell-death patterns. Front Immunol. 2024;15:1410603. https:\/\/doi.org\/10.3389\/fimmu.2024.1410603.","journal-title":"Front Immunol"},{"key":"347_CR108","doi-asserted-by":"publisher","first-page":"103821","DOI":"10.1016\/j.redox.2025.103821","volume":"86","author":"K Arisawa","year":"2025","unstructured":"Arisawa K, Natori M, Hiranuma T, Shimizu M, Yamazaki Y, Miki Y, et al. Nrf2-dependent suppression of selenoprotein P expression promotes intracellular selenium metabolic remodeling and upregulation of antioxidant selenoproteins in hepatocellular carcinoma. Redox Biol. 2025;86:103821. https:\/\/doi.org\/10.1016\/j.redox.2025.103821.","journal-title":"Redox Biol"},{"issue":"33","key":"347_CR109","doi-asserted-by":"publisher","first-page":"e2302953","DOI":"10.1002\/advs.202302953","volume":"10","author":"J Tang","year":"2023","unstructured":"Tang J, Long G, Hu K, Xiao D, Liu S, Xiao L, et al. Targeting USP8 inhibits O-GlcNAcylation of SLC7A11 to promote ferroptosis of hepatocellular carcinoma via stabilization of OGT. Adv Sci. 2023;10(33):e2302953. https:\/\/doi.org\/10.1002\/advs.202302953.","journal-title":"Adv Sci"},{"issue":"1","key":"347_CR110","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/s41419-025-07807-6","volume":"16","author":"X Yue","year":"2025","unstructured":"Yue X, Xiang Z, Yi Y, Wang X, Zhou W, Wu W, et al. Targeting the TRIM14\/USP14 axis enhances radiotherapy efficacy by inducing GPX4 degradation and disrupting ferroptotic defense in HCC. Cell Death Dis. 2025;16(1):481. https:\/\/doi.org\/10.1038\/s41419-025-07807-6.","journal-title":"Cell Death Dis"},{"issue":"1","key":"347_CR111","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1038\/s41419-025-07772-0","volume":"16","author":"S Ye","year":"2025","unstructured":"Ye S, Chen J, Zheng Y, He M, Zhang Y, Cheng Y, et al. Targeting USP18 overcomes acquired resistance in hepatocellular carcinoma by regulating NCOA4 deISGylation and ferroptosis. Cell Death Dis. 2025;16(1):448. https:\/\/doi.org\/10.1038\/s41419-025-07772-0.","journal-title":"Cell Death Dis"},{"issue":"1","key":"347_CR112","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41419-024-07317-x","volume":"16","author":"C Zhang","year":"2025","unstructured":"Zhang C, Yang T, Chen H, Ding X, Chen H, Liang Z, et al. METTL3 inhibition promotes radiosensitivity in hepatocellular carcinoma through regulation of SLC7A11 expression. Cell Death Dis. 2025;16(1):9. https:\/\/doi.org\/10.1038\/s41419-024-07317-x.","journal-title":"Cell Death Dis"},{"key":"347_CR113","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.freeradbiomed.2025.05.429","volume":"237","author":"L Yao","year":"2025","unstructured":"Yao L, Ye S, Xu D. UCHL3 augments cuproptosis via PKM2 deubiquitination in hepatocellular carcinoma. Free Radic Biol Med. 2025;237:65\u201375. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2025.05.429.","journal-title":"Free Radic Biol Med"},{"issue":"11","key":"347_CR114","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1038\/s41419-023-06264-3","volume":"14","author":"Z Li","year":"2023","unstructured":"Li Z, Zhou H, Zhai X, Gao L, Yang M, An B, et al. MELK promotes HCC carcinogenesis through modulating cuproptosis-related gene DLAT-mediated mitochondrial function. Cell Death Dis. 2023;14(11):733. https:\/\/doi.org\/10.1038\/s41419-023-06264-3.","journal-title":"Cell Death Dis"},{"key":"347_CR115","doi-asserted-by":"publisher","first-page":"140523","DOI":"10.1016\/j.ijbiomac.2025.140523","volume":"302","author":"L Wang","year":"2025","unstructured":"Wang L, ChenLiu Z, Wang D, Tang D. Cross-talks of GSH, mitochondria, RNA m6A modification, NRF2, and p53 between ferroptosis and cuproptosis in HCC: a review. Int J Biol Macromol. 2025;302:140523. https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.140523.","journal-title":"Int J Biol Macromol"},{"key":"347_CR116","doi-asserted-by":"publisher","first-page":"116074","DOI":"10.1016\/j.biopha.2023.116074","volume":"170","author":"Z Wang","year":"2024","unstructured":"Wang Z, Zhou C, Zhang Y, Tian X, Wang H, Wu J, et al. From synergy to resistance: navigating the complex relationship between sorafenib and ferroptosis in hepatocellular carcinoma. Biomed Pharmacother. 2024;170:116074. https:\/\/doi.org\/10.1016\/j.biopha.2023.116074.","journal-title":"Biomed Pharmacother"},{"issue":"6","key":"347_CR117","doi-asserted-by":"publisher","first-page":"696","DOI":"10.3390\/antiox13060696","volume":"13","author":"D Baiskhanova","year":"2024","unstructured":"Baiskhanova D, Sch\u00e4fer H. The role of Nrf2 in the regulation of mitochondrial function and ferroptosis in pancreatic cancer. Antioxidants. 2024;13(6):696. https:\/\/doi.org\/10.3390\/antiox13060696.","journal-title":"Antioxidants"},{"issue":"6","key":"347_CR118","doi-asserted-by":"publisher","first-page":"1742","DOI":"10.1038\/s41401-025-01477-y","volume":"46","author":"BR Li","year":"2025","unstructured":"Li BR, Wang T, Hu HF, Wu D, Zhou CJ, Ji SR, et al. Acyl-CoA thioesterase 8 induces gemcitabine resistance via regulation of lipid metabolism and antiferroptotic activity in pancreatic ductal adenocarcinoma. Acta Pharmacol Sin. 2025;46(6):1742\u201356. https:\/\/doi.org\/10.1038\/s41401-025-01477-y.","journal-title":"Acta Pharmacol Sin"},{"key":"347_CR119","doi-asserted-by":"publisher","first-page":"101171","DOI":"10.1016\/j.drup.2024.101171","volume":"78","author":"Z He","year":"2025","unstructured":"He Z, Zheng D, Li F, Chen L, Wu C, Zeng Z, et al. TMOD3 accelerated resistance to immunotherapy in KRAS-mutated pancreatic cancer through promoting autophagy-dependent degradation of ASCL4. Drug Resist Updat. 2025;78:101171. https:\/\/doi.org\/10.1016\/j.drup.2024.101171.","journal-title":"Drug Resist Updat"},{"key":"347_CR120","doi-asserted-by":"publisher","first-page":"217726","DOI":"10.1016\/j.canlet.2025.217726","volume":"623","author":"H Zhang","year":"2025","unstructured":"Zhang H, Ma T, Wen X, Jiang J, Chen J, Jiang J, et al. SIK1 promotes ferroptosis resistance in pancreatic cancer via HDAC5-STAT6-SLC7A11 axis. Cancer Lett. 2025;623:217726. https:\/\/doi.org\/10.1016\/j.canlet.2025.217726.","journal-title":"Cancer Lett"},{"issue":"8074","key":"347_CR121","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1038\/s41586-025-09017-8","volume":"643","author":"G Rademaker","year":"2025","unstructured":"Rademaker G, Hernandez GA, Seo Y, Dahal S, Miller-Phillips L, Li AL, et al. Pcsk9 drives sterol-dependent metastatic organ choice in pancreatic cancer. Nature. 2025;643(8074):1381\u201390. https:\/\/doi.org\/10.1038\/s41586-025-09017-8.","journal-title":"Nature"},{"issue":"7","key":"347_CR122","doi-asserted-by":"publisher","first-page":"1982","DOI":"10.1080\/15548627.2023.2165323","volume":"19","author":"Q Xue","year":"2023","unstructured":"Xue Q, Yan D, Chen X, Li X, Kang R, Klionsky DJ, et al. Copper-dependent autophagic degradation of GPX4 drives ferroptosis. Autophagy. 2023;19(7):1982\u201396. https:\/\/doi.org\/10.1080\/15548627.2023.2165323.","journal-title":"Autophagy"},{"issue":"1","key":"347_CR123","doi-asserted-by":"publisher","first-page":"29579","DOI":"10.1038\/s41598-024-81317-x","volume":"14","author":"J Liu","year":"2024","unstructured":"Liu J, Tang H, Chen F, Li C, Xie Y, Kang R, et al. NFE2L2 and SLC25A39 drive cuproptosis resistance through GSH metabolism. Sci Rep. 2024;14(1):29579. https:\/\/doi.org\/10.1038\/s41598-024-81317-x.","journal-title":"Sci Rep"},{"issue":"1","key":"347_CR124","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s12935-024-03583-z","volume":"25","author":"X Wang","year":"2025","unstructured":"Wang X, Ma M, Shao S, Xu X, Qin C, Gao R, et al. TWIST1 regulates HK2 ubiquitination degradation to promote pancreatic cancer invasion and metastasis. Cancer Cell Int. 2025;25(1):37. https:\/\/doi.org\/10.1186\/s12935-024-03583-z.","journal-title":"Cancer Cell Int"},{"issue":"9","key":"347_CR125","doi-asserted-by":"publisher","first-page":"2091","DOI":"10.3390\/biomedicines12092091","volume":"12","author":"S Amontailak","year":"2024","unstructured":"Amontailak S, Titapun A, Jusakul A, Thanan R, Kimawaha P, Jamnongkan W, et al. Prognostic values of ferroptosis-related proteins ACSL4, SLC7A11, and CHAC1 in cholangiocarcinoma. Biomedicines. 2024;12(9):2091. https:\/\/doi.org\/10.3390\/biomedicines12092091.","journal-title":"Biomedicines"},{"key":"347_CR126","doi-asserted-by":"publisher","first-page":"110710","DOI":"10.1016\/j.cellsig.2023.110710","volume":"108","author":"C Cai","year":"2023","unstructured":"Cai C, Zhu Y, Mu J, Liu S, Yang Z, Wu Z, et al. DNA methylation of RUNX3 promotes the progression of gallbladder cancer through repressing SLC7A11-mediated ferroptosis. Cell Signal. 2023;108:110710. https:\/\/doi.org\/10.1016\/j.cellsig.2023.110710.","journal-title":"Cell Signal"},{"issue":"Pt 1","key":"347_CR127","doi-asserted-by":"publisher","first-page":"146087","DOI":"10.1016\/j.ijbiomac.2025.146087","volume":"321","author":"X Luo","year":"2025","unstructured":"Luo X, Li M, Gong Y, Tao Y, Gong Z, Fan K, et al. FUNDC1 drives cholangiocarcinoma progression via RAC1 interaction and ferroptosis suppression. Int J Biol Macromol. 2025;321(Pt 1):146087. https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.146087.","journal-title":"Int J Biol Macromol"},{"issue":"1","key":"347_CR128","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/s41419-025-07804-9","volume":"16","author":"B Zhang","year":"2025","unstructured":"Zhang B, Lu S, Xiao X, Xu Y, Zhang S, Chen L, et al. Targeting the ROCK2\/UBA52\/DRP1 axis enhances ferroptosis and overcomes pemigatinib resistance in cholangiocarcinoma. Cell Death Dis. 2025;16(1):493. https:\/\/doi.org\/10.1038\/s41419-025-07804-9.","journal-title":"Cell Death Dis"},{"issue":"5","key":"347_CR129","doi-asserted-by":"publisher","first-page":"167152","DOI":"10.1016\/j.bbadis.2024.167152","volume":"1870","author":"Q Zhang","year":"2024","unstructured":"Zhang Q, Zhou J, Zhai D, Jiang Q, Yang M, Zhou M. Gut microbiota regulates the ALK5\/NOX1 axis by altering glutamine metabolism to inhibit ferroptosis of intrahepatic cholangiocarcinoma cells. Biochim Biophys Acta Mol Basis Dis. 2024;1870(5):167152. https:\/\/doi.org\/10.1016\/j.bbadis.2024.167152.","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"issue":"4","key":"347_CR130","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1016\/j.ijrobp.2023.05.031","volume":"117","author":"J Heng","year":"2023","unstructured":"Heng J, Li Z, Liu L, Zheng Z, Zheng Y, Xu X, et al. Acetyl-CoA acetyltransferase 2 confers radioresistance by inhibiting ferroptosis in esophageal squamous cell carcinoma. Int J Radiat Oncol Biol Phys. 2023;117(4):966\u201378. https:\/\/doi.org\/10.1016\/j.ijrobp.2023.05.031.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"6","key":"347_CR131","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1016\/j.ccell.2025.03.031","volume":"43","author":"G Lei","year":"2025","unstructured":"Lei G, Sun M, Cheng J, Ye R, Lu Z, Horbath A, et al. Radiotherapy promotes cuproptosis and synergizes with cuproptosis inducers to overcome tumor radioresistance. Cancer Cell. 2025;43(6):1076-92.e5. https:\/\/doi.org\/10.1016\/j.ccell.2025.03.031.","journal-title":"Cancer Cell"},{"issue":"1","key":"347_CR132","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1038\/s41419-025-07692-z","volume":"16","author":"Z Yang","year":"2025","unstructured":"Yang Z, Zhao K, Li X, Yanzhang R, Zhang H, Yu Y, et al. ZIP8 modulates ferroptosis to drive esophageal carcinoma progression. Cell Death Dis. 2025;16(1):366. https:\/\/doi.org\/10.1038\/s41419-025-07692-z.","journal-title":"Cell Death Dis"},{"issue":"1","key":"347_CR133","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1038\/s41419-025-07773-z","volume":"16","author":"F Ju","year":"2025","unstructured":"Ju F, Weng J, Fan N, Wang Z, Zhou C, Zhao X, et al. AKR1C3 enhances radioresistance in esophageal adenocarcinoma via inhibiting ferroptosis through suppressing TRIM21-mediated ubiquitination of HSPA5. Cell Death Dis. 2025;16(1):483. https:\/\/doi.org\/10.1038\/s41419-025-07773-z.","journal-title":"Cell Death Dis"},{"issue":"1","key":"347_CR134","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1038\/s41420-023-01727-0","volume":"9","author":"R Yang","year":"2023","unstructured":"Yang R, Wan J, Ma L, Zhou F, Yang Z, Li Z, et al. TMEM44-AS1 promotes esophageal squamous cell carcinoma progression by regulating the IGF2BP2-GPX4 axis in modulating ferroptosis. Cell Death Discov. 2023;9(1):431. https:\/\/doi.org\/10.1038\/s41420-023-01727-0.","journal-title":"Cell Death Discov"},{"issue":"1","key":"347_CR135","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1038\/s41420-024-02243-5","volume":"10","author":"Z Chen","year":"2024","unstructured":"Chen Z, Wang W, Hou J, Gao C, Song M, Zhao Z, et al. NEDD4L contributes to ferroptosis and cell growth inhibition in esophageal squamous cell carcinoma by facilitating xCT ubiquitination. Cell Death Discov. 2024;10(1):473. https:\/\/doi.org\/10.1038\/s41420-024-02243-5.","journal-title":"Cell Death Discov"},{"issue":"6","key":"347_CR136","doi-asserted-by":"publisher","first-page":"4219","DOI":"10.21037\/jtd-2025-858","volume":"17","author":"G Zou","year":"2025","unstructured":"Zou G, Cao X, Meng F, Ge Y, Sun R, Chen J, et al. Role of PLEKHA7 in promoting radioresistance in esophageal cancer cells via the inhibition of cuproptosis. J Thorac Dis. 2025;17(6):4219\u201337. https:\/\/doi.org\/10.21037\/jtd-2025-858.","journal-title":"J Thorac Dis"},{"issue":"4","key":"347_CR137","doi-asserted-by":"publisher","first-page":"189124","DOI":"10.1016\/j.bbcan.2024.189124","volume":"1879","author":"M Kciuk","year":"2024","unstructured":"Kciuk M, Gieleci\u0144ska A, Ka\u0142uzi\u0144ska-Ko\u0142at \u017b, Yahya EB, Kontek R. Ferroptosis and cuproptosis: metal-dependent cell death pathways activated in response to classical chemotherapy - significance for cancer treatment? Biochim Biophys Acta Rev Cancer. 2024;1879(4):189124. https:\/\/doi.org\/10.1016\/j.bbcan.2024.189124.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"issue":"23","key":"347_CR138","doi-asserted-by":"publisher","first-page":"e2310309","DOI":"10.1002\/advs.202310309","volume":"11","author":"Y Li","year":"2024","unstructured":"Li Y, Liu J, Chen Y, Weichselbaum RR, Lin W. Nanoparticles synergize ferroptosis and cuproptosis to potentiate cancer immunotherapy. Adv Sci. 2024;11(23):e2310309. https:\/\/doi.org\/10.1002\/advs.202310309.","journal-title":"Adv Sci"},{"issue":"15","key":"347_CR139","doi-asserted-by":"publisher","first-page":"2788","DOI":"10.1158\/0008-5472.Can-24-3478","volume":"85","author":"SL DeAngelo","year":"2025","unstructured":"DeAngelo SL, Zhao L, Dziechciarz S, Shin M, Solanki S, Balia A, et al. Recharacterization of the Tumor Suppressive Mechanism of RSL3 Identifies the Selenoproteome as a druggable pathway in colorectal cancer. Cancer Res. 2025;85(15):2788\u2013804. https:\/\/doi.org\/10.1158\/0008-5472.Can-24-3478.","journal-title":"Cancer Res"},{"key":"347_CR140","doi-asserted-by":"publisher","first-page":"110866","DOI":"10.1016\/j.cbi.2024.110866","volume":"389","author":"L Zhao","year":"2024","unstructured":"Zhao L, Miao H, Quan M, Wang S, Zhang Y, Zhou H, et al. \u03b2-Lapachone induces ferroptosis of colorectal cancer cells via NCOA4-mediated ferritinophagy by activating JNK pathway. Chem Biol Interact. 2024;389:110866. https:\/\/doi.org\/10.1016\/j.cbi.2024.110866.","journal-title":"Chem Biol Interact"},{"issue":"1","key":"347_CR141","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1038\/s41598-018-19213-4","volume":"8","author":"M Sato","year":"2018","unstructured":"Sato M, Kusumi R, Hamashima S, Kobayashi S, Sasaki S, Komiyama Y, et al. The ferroptosis inducer erastin irreversibly inhibits system xc- and synergizes with cisplatin to increase cisplatin\u2019s cytotoxicity in cancer cells. Sci Rep. 2018;8(1):968. https:\/\/doi.org\/10.1038\/s41598-018-19213-4.","journal-title":"Sci Rep"},{"key":"347_CR142","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.freeradbiomed.2025.06.029","volume":"238","author":"X Liu","year":"2025","unstructured":"Liu X, Long G, Wang Q, Wang J, Chen X, Zhou Y, et al. ANG secretion predisposes endothelial cells toward angiogenesis in FIN56-induced ferroptotic hepatocellular carcinoma via the BMP6\/ID1 signaling pathway. Free Radic Biol Med. 2025;238:17\u201335. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2025.06.029.","journal-title":"Free Radic Biol Med"},{"issue":"11","key":"347_CR143","first-page":"6417","volume":"34","author":"E Lachaier","year":"2014","unstructured":"Lachaier E, Louandre C, Godin C, Saidak Z, Baert M, Diouf M, et al. Sorafenib induces ferroptosis in human cancer cell lines originating from different solid tumors. Anticancer Res. 2014;34(11):6417\u201322.","journal-title":"Anticancer Res"},{"issue":"8","key":"347_CR144","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1038\/s41401-024-01258-z","volume":"45","author":"JQ Lai","year":"2024","unstructured":"Lai JQ, Zhao LL, Hong C, Zou QM, Su JX, Li SJ, et al. Baicalein triggers ferroptosis in colorectal cancer cells via blocking the JAK2\/STAT3\/GPX4 axis. Acta Pharmacol Sin. 2024;45(8):1715\u201326. https:\/\/doi.org\/10.1038\/s41401-024-01258-z.","journal-title":"Acta Pharmacol Sin"},{"issue":"5","key":"347_CR145","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1038\/s41589-018-0031-6","volume":"14","author":"MM Gaschler","year":"2018","unstructured":"Gaschler MM, Andia AA, Liu H, Csuka JM, Hurlocker B, Vaiana CA, et al. FINO2 initiates ferroptosis through GPX4 inactivation and iron oxidation. Nat Chem Biol. 2018;14(5):507\u201315. https:\/\/doi.org\/10.1038\/s41589-018-0031-6.","journal-title":"Nat Chem Biol"},{"key":"347_CR146","doi-asserted-by":"publisher","first-page":"156804","DOI":"10.1016\/j.phymed.2025.156804","volume":"142","author":"A Ke","year":"2025","unstructured":"Ke A, Yang W, Zhang W, Chen Y, Meng X, Liu J, et al. The cardiac glycoside periplocymarin sensitizes gastric cancer to ferroptosis via the ATP1A1-Src-YAP\/TAZ-TFRC axis. Phytomedicine. 2025;142:156804. https:\/\/doi.org\/10.1016\/j.phymed.2025.156804.","journal-title":"Phytomedicine"},{"key":"347_CR147","doi-asserted-by":"publisher","first-page":"116257","DOI":"10.1016\/j.bcp.2024.116257","volume":"225","author":"R Jenke","year":"2024","unstructured":"Jenke R, Oliinyk D, Zenz T, K\u00f6rfer J, Sch\u00e4ker-H\u00fcbner L, Hansen FK, et al. HDAC inhibitors activate lipid peroxidation and ferroptosis in gastric cancer. Biochem Pharmacol. 2024;225:116257. https:\/\/doi.org\/10.1016\/j.bcp.2024.116257.","journal-title":"Biochem Pharmacol"},{"key":"347_CR148","doi-asserted-by":"publisher","first-page":"156224","DOI":"10.1016\/j.phymed.2024.156224","volume":"136","author":"W Haoyue","year":"2025","unstructured":"Haoyue W, Kexiang S, Shan TW, Jiamin G, Luyun Y, Junkai W, et al. Icariin promoted ferroptosis by activating mitochondrial dysfunction to inhibit colorectal cancer and synergistically enhanced the efficacy of PD-1 inhibitors. Phytomedicine. 2025;136:156224. https:\/\/doi.org\/10.1016\/j.phymed.2024.156224.","journal-title":"Phytomedicine"},{"key":"347_CR149","doi-asserted-by":"publisher","first-page":"1389179","DOI":"10.3389\/fphar.2024.1389179","volume":"15","author":"F Xiong","year":"2024","unstructured":"Xiong F, Zhang Y, Li T, Tang Y, Song SY, Zhou Q, et al. A detailed overview of quercetin: implications for cell death and liver fibrosis mechanisms. Front Pharmacol. 2024;15:1389179. https:\/\/doi.org\/10.3389\/fphar.2024.1389179.","journal-title":"Front Pharmacol"},{"key":"347_CR150","doi-asserted-by":"publisher","unstructured":"Liu Z, Ma H, Lai Z. The role of ferroptosis and cuproptosis in curcumin against hepatocellular carcinoma. Molecules. 2023;28(4). https:\/\/doi.org\/10.3390\/molecules28041623.","DOI":"10.3390\/molecules28041623"},{"key":"347_CR151","doi-asserted-by":"publisher","first-page":"107553","DOI":"10.1016\/j.phrs.2024.107553","volume":"211","author":"C Xu","year":"2025","unstructured":"Xu C, Wen S, Du X, Zou X, Leung EL, Zhou G, et al. Targeting regulated cell death (RCD) with naturally derived sesquiterpene lactones in cancer therapy. Pharmacol Res. 2025;211:107553. https:\/\/doi.org\/10.1016\/j.phrs.2024.107553.","journal-title":"Pharmacol Res"},{"issue":"9","key":"347_CR152","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.1136\/gutjnl-2022-327909","volume":"72","author":"C Conche","year":"2023","unstructured":"Conche C, Finkelmeier F, Pe\u0161i\u0107 M, Nicolas AM, B\u00f6ttger TW, Kennel KB, et al. Combining ferroptosis induction with MDSC blockade renders primary tumours and metastases in liver sensitive to immune checkpoint blockade. Gut. 2023;72(9):1774\u201382. https:\/\/doi.org\/10.1136\/gutjnl-2022-327909.","journal-title":"Gut"},{"key":"347_CR153","doi-asserted-by":"publisher","first-page":"114301","DOI":"10.1016\/j.biopha.2023.114301","volume":"159","author":"W Yang","year":"2023","unstructured":"Yang W, Wang Y, Huang Y, Yu J, Wang T, Li C, et al. 4-octyl itaconate inhibits aerobic glycolysis by targeting GAPDH to promote cuproptosis in colorectal cancer. Biomed Pharmacother. 2023;159:114301. https:\/\/doi.org\/10.1016\/j.biopha.2023.114301.","journal-title":"Biomed Pharmacother"},{"key":"347_CR154","doi-asserted-by":"publisher","first-page":"101427","DOI":"10.1016\/j.mtbio.2024.101427","volume":"30","author":"X Yan","year":"2025","unstructured":"Yan X, Liu H, Guo L, Liu C, Zhang S, Wang X, et al. Multifunctional drug delivery nanoparticles for combined chemotherapy\/chemodynamic\/photothermal therapy against colorectal cancer through synergistic cuproptosis\/ferroptosis\/apoptosis. Mater Today Bio. 2025;30:101427. https:\/\/doi.org\/10.1016\/j.mtbio.2024.101427.","journal-title":"Mater Today Bio"},{"issue":"2","key":"347_CR155","doi-asserted-by":"publisher","first-page":"e2403493","DOI":"10.1002\/adhm.202403493","volume":"14","author":"Y Hu","year":"2025","unstructured":"Hu Y, Yu Q, Li X, Wang J, Guo L, Huang L, et al. Nanoformula design for inducing non-apoptotic cell death regulation: a powerful booster for cancer immunotherapy. Adv Healthc Mater. 2025;14(2):e2403493. https:\/\/doi.org\/10.1002\/adhm.202403493.","journal-title":"Adv Healthc Mater"},{"issue":"3","key":"347_CR156","doi-asserted-by":"publisher","first-page":"e2306580","DOI":"10.1002\/advs.202306580","volume":"11","author":"Y Li","year":"2024","unstructured":"Li Y, Guo Y, Zhang K, Zhu R, Chen X, Zhang Z, et al. Cell death pathway regulation by functional nanomedicines for robust antitumor immunity. Adv Sci (Weinh). 2024;11(3):e2306580. https:\/\/doi.org\/10.1002\/advs.202306580.","journal-title":"Adv Sci (Weinh)"},{"key":"347_CR157","doi-asserted-by":"publisher","unstructured":"Yang X, Luo W, Wang Y, Du Y, Yu R. Recent advances in nanotechnology-based approaches for ferroptosis therapy and imaging diagnosis in pancreatic cancer. Pharmaceutics. 2025;17(7). https:\/\/doi.org\/10.3390\/pharmaceutics17070937.","DOI":"10.3390\/pharmaceutics17070937"},{"key":"347_CR158","doi-asserted-by":"publisher","first-page":"101848","DOI":"10.1016\/j.mtbio.2025.101848","volume":"32","author":"Y Yan","year":"2025","unstructured":"Yan Y, Hu J, Han N, Li HT, Yang X, Li LG, et al. Sorafenib-loaded metal-organic framework nanoparticles for anti-hepatocellular carcinoma effects through synergistically potentiating ferroptosis and remodeling tumor immune microenvironment. Mater Today Bio. 2025;32:101848. https:\/\/doi.org\/10.1016\/j.mtbio.2025.101848.","journal-title":"Mater Today Bio"},{"issue":"1","key":"347_CR159","doi-asserted-by":"publisher","first-page":"e2402697","DOI":"10.1002\/adhm.202402697","volume":"14","author":"M Luo","year":"2025","unstructured":"Luo M, Wang YM, Zhao FK, Luo Y. Recent advances in nanomaterial-mediated cell death for cancer therapy. Adv Healthc Mater. 2025;14(1):e2402697. https:\/\/doi.org\/10.1002\/adhm.202402697.","journal-title":"Adv Healthc Mater"},{"key":"347_CR160","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.actbio.2025.01.014","volume":"193","author":"S Zhang","year":"2025","unstructured":"Zhang S, Peng S. Copper-based biomaterials for anti-tumor therapy: recent advances and perspectives. Acta Biomater. 2025;193:107\u201327. https:\/\/doi.org\/10.1016\/j.actbio.2025.01.014.","journal-title":"Acta Biomater"},{"issue":"1","key":"347_CR161","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1186\/s12951-024-02859-w","volume":"22","author":"X Meng","year":"2024","unstructured":"Meng X, Shen Y, Zhao H, Lu X, Wang Z, Zhao Y. Redox-manipulating nanocarriers for anticancer drug delivery: a systematic review. J Nanobiotechnology. 2024;22(1):587. https:\/\/doi.org\/10.1186\/s12951-024-02859-w.","journal-title":"J Nanobiotechnology"},{"issue":"6","key":"347_CR162","doi-asserted-by":"publisher","first-page":"9155","DOI":"10.1021\/acsami.4c21890","volume":"17","author":"X Chen","year":"2025","unstructured":"Chen X, Zhang F, Lu C, Wu R, Yang B, Liao T, et al. Lactate-fueled theranostic nanoplatforms for enhanced MRI-guided ferroptosis synergistic with immunotherapy of hepatocellular carcinoma. ACS Appl Mater Interfaces. 2025;17(6):9155\u201372. https:\/\/doi.org\/10.1021\/acsami.4c21890.","journal-title":"ACS Appl Mater Interfaces"},{"issue":"5","key":"347_CR163","doi-asserted-by":"publisher","first-page":"6260","DOI":"10.1021\/acsami.2c14962","volume":"15","author":"J Liu","year":"2023","unstructured":"Liu J, Li X, Chen J, Zhang X, Guo J, Gu J, et al. Arsenic-loaded biomimetic iron oxide nanoparticles for enhanced ferroptosis-inducing therapy of hepatocellular carcinoma. ACS Appl Mater Interfaces. 2023;15(5):6260\u201373. https:\/\/doi.org\/10.1021\/acsami.2c14962.","journal-title":"ACS Appl Mater Interfaces"},{"issue":"3","key":"347_CR164","doi-asserted-by":"publisher","first-page":"5735","DOI":"10.1021\/acsnano.1c01248","volume":"15","author":"X Meng","year":"2021","unstructured":"Meng X, Li D, Chen L, He H, Wang Q, Hong C, et al. High-performance self-cascade pyrite nanozymes for apoptosis-ferroptosis synergistic tumor therapy. ACS Nano. 2021;15(3):5735\u201351. https:\/\/doi.org\/10.1021\/acsnano.1c01248.","journal-title":"ACS Nano"},{"key":"347_CR165","doi-asserted-by":"publisher","first-page":"1451067","DOI":"10.3389\/fphar.2024.1451067","volume":"15","author":"X Liu","year":"2024","unstructured":"Liu X, Zhang W, Wei S, Liang X, Luo B. Targeting cuproptosis with nano material: new way to enhancing the efficacy of immunotherapy in colorectal cancer. Front Pharmacol. 2024;15:1451067. https:\/\/doi.org\/10.3389\/fphar.2024.1451067.","journal-title":"Front Pharmacol"},{"issue":"4","key":"347_CR166","doi-asserted-by":"publisher","first-page":"e2302537","DOI":"10.1002\/adhm.202302537","volume":"13","author":"Y Ruan","year":"2024","unstructured":"Ruan Y, Zhuang H, Zeng X, Lin L, Wang X, Xue P, et al. Engineered microbial nanohybrids for tumor-mediated NIR II photothermal enhanced ferroptosis\/cuproptosis and immunotherapy. Adv Healthc Mater. 2024;13(4):e2302537. https:\/\/doi.org\/10.1002\/adhm.202302537.","journal-title":"Adv Healthc Mater"},{"issue":"6","key":"347_CR167","doi-asserted-by":"publisher","first-page":"e2413422","DOI":"10.1002\/advs.202413422","volume":"12","author":"S Dong","year":"2025","unstructured":"Dong S, Cao H, Yuan Y, Liang S, Fu Z, Shi W, et al. A Novel, \u201cThree-in-One\u201d copper-based metal-organic framework nanozyme eradicates colorectal cancer and overcomes chemoresistance for tumor therapy. Adv Sci (Weinh). 2025;12(6):e2413422. https:\/\/doi.org\/10.1002\/advs.202413422.","journal-title":"Adv Sci (Weinh)"},{"issue":"35","key":"347_CR168","doi-asserted-by":"publisher","first-page":"e2403520","DOI":"10.1002\/advs.202403520","volume":"11","author":"Y Li","year":"2024","unstructured":"Li Y, Liu J, Weichselbaum RR, Lin W. Mitochondria-targeted multifunctional nanoparticles combine cuproptosis and programmed cell death-1 downregulation for cancer immunotherapy. Adv Sci. 2024;11(35):e2403520. https:\/\/doi.org\/10.1002\/advs.202403520.","journal-title":"Adv Sci"},{"issue":"5","key":"347_CR169","doi-asserted-by":"publisher","first-page":"2640","DOI":"10.1016\/j.apsb.2025.03.014","volume":"15","author":"M Hamza","year":"2025","unstructured":"Hamza M, Wang S, Wu H, Sun J, Du Y, Zeng C, et al. Targeting copper homeostasis: Akkermansia-derived OMVs co-deliver Atox1 siRNA and elesclomol for cancer therapy. Acta Pharm Sin B. 2025;15(5):2640\u201354. https:\/\/doi.org\/10.1016\/j.apsb.2025.03.014.","journal-title":"Acta Pharm Sin B"},{"issue":"40","key":"347_CR170","doi-asserted-by":"publisher","first-page":"e2400326","DOI":"10.1002\/smll.202400326","volume":"20","author":"J Bai","year":"2024","unstructured":"Bai J, Zhang X, Zhao Z, Sun S, Cheng W, Yu H, et al. CuO nanozymes catalyze cysteine and glutathione depletion induced ferroptosis and cuproptosis for synergistic tumor therapy. Small. 2024;20(40):e2400326. https:\/\/doi.org\/10.1002\/smll.202400326.","journal-title":"Small"},{"issue":"29","key":"347_CR171","doi-asserted-by":"publisher","first-page":"e2401361","DOI":"10.1002\/adma.202401361","volume":"36","author":"C Ding","year":"2024","unstructured":"Ding C, Min J, Tan Y, Zheng L, Ma R, Zhao R, et al. Combating atherosclerosis with chirality\/phase dual-engineered nanozyme featuring microenvironment-programmed senolytic and senomorphic actions. Adv Mater. 2024;36(29):e2401361. https:\/\/doi.org\/10.1002\/adma.202401361.","journal-title":"Adv Mater"},{"issue":"33","key":"347_CR172","doi-asserted-by":"publisher","first-page":"e2303694","DOI":"10.1002\/advs.202303694","volume":"10","author":"W Chen","year":"2023","unstructured":"Chen W, Xie W, Gao Z, Lin C, Tan M, Zhang Y, et al. Mild-photothermal effect induced high efficiency ferroptosis-boosted-cuproptosis based on Cu(2) O@Mn(3) Cu(3) O(8) nanozyme. Adv Sci. 2023;10(33):e2303694. https:\/\/doi.org\/10.1002\/advs.202303694.","journal-title":"Adv Sci"},{"key":"347_CR173","doi-asserted-by":"publisher","unstructured":"Liu C, Guo L, Cheng Y, Gao J, Pan H, Zhu J et al. A mitochondria-targeted nanozyme platform for multi-pathway tumor therapy via ferroptosis and cuproptosis regulation. Adv Sci (Weinh). 2025:e17616. https:\/\/doi.org\/10.1002\/advs.202417616.","DOI":"10.1002\/advs.202417616"},{"issue":"31","key":"347_CR174","doi-asserted-by":"publisher","first-page":"44922","DOI":"10.1021\/acsami.5c09045","volume":"17","author":"M Dong","year":"2025","unstructured":"Dong M, Liu Y, Xiao Y, Wu Q, Guan M, Xiao Z, et al. Tumor-Targeted PLGA Nanospheres Enhance Therapeutic Effect of Lenvatinib in Hepatocellular Carcinoma via Photothermal and Photodynamic Therapy. ACS Appl Mater Interfaces. 2025;17(31):44922\u201338. https:\/\/doi.org\/10.1021\/acsami.5c09045.","journal-title":"ACS Appl Mater Interfaces"},{"issue":"29","key":"347_CR175","doi-asserted-by":"publisher","first-page":"41586","DOI":"10.1021\/acsami.5c05523","volume":"17","author":"J Luo","year":"2025","unstructured":"Luo J, Xu L, Feng J, Xu K, Tian P, Bai X, et al. Tumor microenvironment-activated and ROS-augmented nanoplatform amplified PDT against colorectal cancer through impairing GPX4 to induce ferroptosis. ACS Appl Mater Interfaces. 2025;17(29):41586\u201396. https:\/\/doi.org\/10.1021\/acsami.5c05523.","journal-title":"ACS Appl Mater Interfaces"},{"issue":"43","key":"347_CR176","doi-asserted-by":"publisher","first-page":"29804","DOI":"10.1021\/acsnano.4c09500","volume":"18","author":"Q Tang","year":"2024","unstructured":"Tang Q, Wang Y, Yan B, Zhang J, Wang T, Fang Y, et al. Intracellular magnetic hyperthermia sensitizes Sorafenib to orthotopic hepatocellular carcinoma via amplified ferroptosis. ACS Nano. 2024;18(43):29804\u201319. https:\/\/doi.org\/10.1021\/acsnano.4c09500.","journal-title":"ACS Nano"},{"issue":"4","key":"347_CR177","doi-asserted-by":"publisher","first-page":"3518","DOI":"10.1021\/acsnano.2c09893","volume":"17","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Zhang C, Wu B, Li C, Lin J, Huang P. Thermoresponsive ozone-enriched spray gel for postsurgical treatment of hepatocellular carcinoma. ACS Nano. 2023;17(4):3518\u201327. https:\/\/doi.org\/10.1021\/acsnano.2c09893.","journal-title":"ACS Nano"},{"issue":"40","key":"347_CR178","doi-asserted-by":"publisher","first-page":"27597","DOI":"10.1021\/acsnano.4c08690","volume":"18","author":"L Zheng","year":"2024","unstructured":"Zheng L, Ding Y, Fang S, Yang W, Chen J, Ma J, et al. Potentiated calcium carbonate with enhanced calcium overload induction and acid neutralization capabilities to boost chemoimmunotherapy against liver cancer. ACS Nano. 2024;18(40):27597\u2013616. https:\/\/doi.org\/10.1021\/acsnano.4c08690.","journal-title":"ACS Nano"},{"issue":"19","key":"347_CR179","doi-asserted-by":"publisher","first-page":"18188","DOI":"10.1021\/acsnano.4c16846","volume":"19","author":"H Liu","year":"2025","unstructured":"Liu H, Yang Y, Zhang N, Hou Y, Zhang Z, Yu X, et al. Overcoming photothermal resistance of gastric cancer by bionic 2D iron-based nanoplatforms with precise CRISPR\/Cas9 delivery. ACS Nano. 2025;19(19):18188\u2013202. https:\/\/doi.org\/10.1021\/acsnano.4c16846.","journal-title":"ACS Nano"},{"issue":"32","key":"347_CR180","doi-asserted-by":"publisher","first-page":"29341","DOI":"10.1021\/acsnano.5c06115","volume":"19","author":"J Liu","year":"2025","unstructured":"Liu J, Wu M, Yang C, Zhou Y, Qi X, Chen K, et al. Synergizing ferroptosis suppressor protein 1 gene silencing and photodynamic therapy based on photosensitive lipid nanoparticles for colon cancer immunotherapy. ACS Nano. 2025;19(32):29341\u201359. https:\/\/doi.org\/10.1021\/acsnano.5c06115.","journal-title":"ACS Nano"},{"key":"347_CR181","doi-asserted-by":"publisher","unstructured":"Zhou X, Zhang Q, Zhu H, Ouyang G, Wang X, Cai Y. High carbonyl graphene oxide suppresses colorectal cancer cell proliferation and migration by inducing ferroptosis via the system Xc-\/GSH\/GPX4 Axis. Pharmaceutics. 2024;16(12). https:\/\/doi.org\/10.3390\/pharmaceutics16121605.","DOI":"10.3390\/pharmaceutics16121605"},{"issue":"23","key":"347_CR182","doi-asserted-by":"publisher","first-page":"23998","DOI":"10.1021\/acsnano.3c08875","volume":"17","author":"W Shen","year":"2023","unstructured":"Shen W, Pei P, Zhang C, Li J, Han X, Liu T, et al. A polymeric hydrogel to eliminate programmed death-ligand 1 for enhanced tumor radio-immunotherapy. ACS Nano. 2023;17(23):23998\u20134011. https:\/\/doi.org\/10.1021\/acsnano.3c08875.","journal-title":"ACS Nano"},{"issue":"6","key":"347_CR183","doi-asserted-by":"publisher","first-page":"e2403939","DOI":"10.1002\/adhm.202403939","volume":"14","author":"W Shang","year":"2025","unstructured":"Shang W, Xia X, Zhu Y, Chen Q, Rao X, Huang L, et al. Three-level nanoparticle rocket strategy for colorectal cancer therapeutics in photothermal therapy, inflammation modulation, and cuproptosis induction. Adv Healthc Mater. 2025;14(6):e2403939. https:\/\/doi.org\/10.1002\/adhm.202403939.","journal-title":"Adv Healthc Mater"},{"key":"347_CR184","doi-asserted-by":"publisher","unstructured":"Wang Y, Pi W, Shao Y, Tan X, Wang P, Yu H. Natural small molecule self-assembled hydrogel inhibited colorectal cancer progression by regulating cuproptosis and PANoptosis. Adv Healthc Mater. 2025:e01675. https:\/\/doi.org\/10.1002\/adhm.202501675.","DOI":"10.1002\/adhm.202501675"},{"issue":"18","key":"347_CR185","doi-asserted-by":"publisher","first-page":"e2417676","DOI":"10.1002\/advs.202417676","volume":"12","author":"S Gao","year":"2025","unstructured":"Gao S, Ge H, Gao L, Gao Y, Tang S, Li Y, et al. Silk fibroin nanoparticles for enhanced cuproptosis and immunotherapy in pancreatic cancer treatment. Adv Sci. 2025;12(18):e2417676. https:\/\/doi.org\/10.1002\/advs.202417676.","journal-title":"Adv Sci"},{"issue":"13","key":"347_CR186","doi-asserted-by":"publisher","first-page":"e2309388","DOI":"10.1002\/advs.202309388","volume":"11","author":"F Hu","year":"2024","unstructured":"Hu F, Huang J, Bing T, Mou W, Li D, Zhang H, et al. Stimulus-responsive copper complex nanoparticles induce cuproptosis for augmented cancer immunotherapy. Adv Sci. 2024;11(13):e2309388. https:\/\/doi.org\/10.1002\/advs.202309388.","journal-title":"Adv Sci"},{"key":"347_CR187","doi-asserted-by":"publisher","first-page":"114196","DOI":"10.1016\/j.colsurfb.2024.114196","volume":"245","author":"Y Wan","year":"2025","unstructured":"Wan Y, Chen J, Li J, Chen Z, Wang Y, Li J, et al. Cu(0)-based nanoparticles boost anti-tumor efficacy via synergy of cuproptosis and ferroptosis enhanced by cuproptosis-induced glutathione synthesis disorder. Colloids Surf B Biointerfaces. 2025;245:114196. https:\/\/doi.org\/10.1016\/j.colsurfb.2024.114196.","journal-title":"Colloids Surf B Biointerfaces"},{"key":"347_CR188","doi-asserted-by":"publisher","first-page":"114059","DOI":"10.1016\/j.jconrel.2025.114059","volume":"385","author":"L Liang","year":"2025","unstructured":"Liang L, Zhu Z, Jiang X, Tang Y, Li J, Zhang Z, et al. Endoplasmic reticulum-targeted strategies for programmed cell death in cancer therapy: approaches and prospects. J Control Release. 2025;385:114059. https:\/\/doi.org\/10.1016\/j.jconrel.2025.114059.","journal-title":"J Control Release"},{"issue":"43","key":"347_CR189","doi-asserted-by":"publisher","first-page":"58203","DOI":"10.1021\/acsami.4c10336","volume":"16","author":"W Li","year":"2024","unstructured":"Li W, Wang H, Liu Y, Li B, Wang F, Ye P, et al. \u201cTrinity\u201d Comprehensively Regulates the Tumor Microenvironment of Lipid-Coated CaCO(3)@CuO(2) Nanoparticles Induces \u201cCuproptosis\u201d in HCC. ACS Appl Mater Interfaces. 2024;16(43):58203\u201316. https:\/\/doi.org\/10.1021\/acsami.4c10336.","journal-title":"ACS Appl Mater Interfaces"},{"issue":"1","key":"347_CR190","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1186\/s12951-024-02480-x","volume":"22","author":"L Qiao","year":"2024","unstructured":"Qiao L, Ou Y, Li L, Wu S, Guo Y, Liu M, et al. H(2)S-driven chemotherapy and mild photothermal therapy induced mitochondrial reprogramming to promote cuproptosis. J Nanobiotechnology. 2024;22(1):205. https:\/\/doi.org\/10.1186\/s12951-024-02480-x.","journal-title":"J Nanobiotechnology"},{"issue":"11","key":"347_CR191","doi-asserted-by":"publisher","first-page":"e2401747","DOI":"10.1002\/adhm.202401747","volume":"14","author":"F Xuan","year":"2025","unstructured":"Xuan F, Zhao X, Pang W, Li Z, Yin X, Xie W, et al. Biomimetic co-delivery of Lenvatinib and FePt nanoparticles for enhanced ferroptosis\/apoptosis treatment of hepatocellular carcinoma. Adv Healthc Mater. 2025;14(11):e2401747. https:\/\/doi.org\/10.1002\/adhm.202401747.","journal-title":"Adv Healthc Mater"},{"issue":"1","key":"347_CR192","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1186\/s13045-022-01392-3","volume":"15","author":"X Tong","year":"2022","unstructured":"Tong X, Tang R, Xiao M, Xu J, Wang W, Zhang B, et al. Targeting cell death pathways for cancer therapy: recent developments in necroptosis, pyroptosis, ferroptosis, and cuproptosis research. J Hematol Oncol. 2022;15(1):174. https:\/\/doi.org\/10.1186\/s13045-022-01392-3.","journal-title":"J Hematol Oncol"},{"issue":"1","key":"347_CR193","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1515\/jtim-2025-0004","volume":"13","author":"Z Guo","year":"2025","unstructured":"Guo Z, Liu Y, Chen D, Sun Y, Li D, Meng Y, et al. Targeting regulated cell death: apoptosis, necroptosis, pyroptosis, ferroptosis, and cuproptosis in anticancer immunity. J Transl Intern Med. 2025;13(1):10\u201332. https:\/\/doi.org\/10.1515\/jtim-2025-0004.","journal-title":"J Transl Intern Med"},{"key":"347_CR194","doi-asserted-by":"publisher","unstructured":"Yang LJ, Pan MM, Hu H, Liu F, Jiang M, Ning S et al. Bioinspired Dual-Ionic-Site Single-Atom Nanozymes for Synergistic Ferroptosis\/Cuproptosis and Enhanced Immune Checkpoint Blockade Therapy. Small. 2025:e2501076. https:\/\/doi.org\/10.1002\/smll.202501076.","DOI":"10.1002\/smll.202501076"},{"key":"347_CR195","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/j.actbio.2024.12.010","volume":"193","author":"C Tang","year":"2025","unstructured":"Tang C, Liu K, Gao X, Kang H, Xie W, Chang J, et al. A metal-organic framework functionalized CaO(2)-based cascade nanoreactor induces synergistic cuproptosis\/ferroptosis and Ca(2+) overload-mediated mitochondrial damage for enhanced sono-chemodynamic immunotherapy. Acta Biomater. 2025;193:455\u201373. https:\/\/doi.org\/10.1016\/j.actbio.2024.12.010.","journal-title":"Acta Biomater"},{"key":"347_CR196","doi-asserted-by":"publisher","unstructured":"Xie T, Shan Y, Topatana W, Yang T, Shen R, Li S et al. targeted intracellular copper reservoir enhances liver cancer immunotherapy. Small. 2025:e02783. https:\/\/doi.org\/10.1002\/smll.202502783.","DOI":"10.1002\/smll.202502783"},{"key":"347_CR197","doi-asserted-by":"publisher","first-page":"102135","DOI":"10.1016\/j.mtbio.2025.102135","volume":"34","author":"B Bai","year":"2025","unstructured":"Bai B, Zheng Z, Zhu B, Wu J, Xu Y, Zhong X, et al. An Fe(III)-covalent organic framework (COF)-sorafenib nanoplatform induces chemo-ferroptosis for enhanced hepatocellular carcinoma immunotherapy. Mater Today Bio. 2025;34:102135. https:\/\/doi.org\/10.1016\/j.mtbio.2025.102135.","journal-title":"Mater Today Bio"},{"key":"347_CR198","doi-asserted-by":"publisher","first-page":"123201","DOI":"10.1016\/j.biomaterials.2025.123201","volume":"319","author":"J Li","year":"2025","unstructured":"Li J, Zhang G, Sun Z, Jiang M, Jia G, Liu H, et al. Immunogenic cuproptosis in cancer immunotherapy via an in situ cuproptosis-inducing system. Biomaterials. 2025;319:123201. https:\/\/doi.org\/10.1016\/j.biomaterials.2025.123201.","journal-title":"Biomaterials"},{"issue":"5","key":"347_CR199","doi-asserted-by":"publisher","first-page":"e2406975","DOI":"10.1002\/advs.202406975","volume":"12","author":"L Shen","year":"2025","unstructured":"Shen L, Yang Z, Zhong Y, Bi Y, Yu J, Lu Q, et al. Cholesterol targeted catalytic hydrogel fueled by tumor debris can enhance microwave ablation therapy and anti-tumor immune response. Adv Sci (Weinh). 2025;12(5):e2406975. https:\/\/doi.org\/10.1002\/advs.202406975.","journal-title":"Adv Sci (Weinh)"},{"issue":"12","key":"347_CR200","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1158\/2159-8290.CD-19-0338","volume":"9","author":"X Lang","year":"2019","unstructured":"Lang X, Green MD, Wang W, Yu J, Choi JE, Jiang L, et al. Radiotherapy and immunotherapy promote tumoral lipid oxidation and ferroptosis via synergistic repression of SLC7A11. Cancer Discov. 2019;9(12):1673\u201385. https:\/\/doi.org\/10.1158\/2159-8290.CD-19-0338.","journal-title":"Cancer Discov"},{"issue":"1","key":"347_CR201","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s40164-025-00653-4","volume":"14","author":"W Jing","year":"2025","unstructured":"Jing W, Wang W, Ding Y, Zeng R, Zhu H, Kang Z, et al. GLS2 inhibition synergizes with copper to reprogram TCA cycle for cuproptosis-driven radiosensitization in esophageal cancer. Exp Hematol Oncol. 2025;14(1):55. https:\/\/doi.org\/10.1186\/s40164-025-00653-4.","journal-title":"Exp Hematol Oncol"},{"issue":"7","key":"347_CR202","doi-asserted-by":"publisher","first-page":"757","DOI":"10.3390\/antiox13070757","volume":"13","author":"C Brignola","year":"2024","unstructured":"Brignola C, Pecoraro A, Danisi C, Iaccarino N, Di Porzio A, Romano F, et al. Ul3 regulates redox metabolism and ferroptosis sensitivity of p53-deleted colorectal cancer cells. Antioxidants. 2024;13(7):757. https:\/\/doi.org\/10.3390\/antiox13070757.","journal-title":"Antioxidants"},{"key":"347_CR203","doi-asserted-by":"publisher","first-page":"1056932","DOI":"10.3389\/fimmu.2022.1056932","volume":"13","author":"J Wang","year":"2022","unstructured":"Wang J, Qin D, Tao Z, Wang B, Xie Y, Wang Y, et al. Identification of cuproptosis-related subtypes, construction of a prognosis model, and tumor microenvironment landscape in gastric cancer. Front Immunol. 2022;13:1056932. https:\/\/doi.org\/10.3389\/fimmu.2022.1056932.","journal-title":"Front Immunol"},{"issue":"1","key":"347_CR204","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s12935-022-02836-z","volume":"23","author":"J Li","year":"2023","unstructured":"Li J, Yin J, Li W, Wang H, Ni B. Molecular subtypes based on cuproptosis-related genes and tumor microenvironment infiltration characteristics in pancreatic adenocarcinoma. Cancer Cell Int. 2023;23(1):7. https:\/\/doi.org\/10.1186\/s12935-022-02836-z.","journal-title":"Cancer Cell Int"},{"key":"347_CR205","doi-asserted-by":"publisher","first-page":"999193","DOI":"10.3389\/fonc.2023.999193","volume":"13","author":"H Luo","year":"2023","unstructured":"Luo H, Zhang Q, Liu X, Luo Y, Jiang X, Wang C, et al. Molecular subtypes and tumor microenvironment infiltration signatures based on cuproptosis-related genes in colon cancer. Front Oncol. 2023;13:999193. https:\/\/doi.org\/10.3389\/fonc.2023.999193.","journal-title":"Front Oncol"},{"key":"347_CR206","doi-asserted-by":"publisher","first-page":"1172895","DOI":"10.3389\/fcell.2023.1172895","volume":"11","author":"G Chen","year":"2023","unstructured":"Chen G, Luo D, Qi X, Li D, Zheng J, Luo Y, et al. Characterization of cuproptosis in gastric cancer and relationship with clinical and drug reactions. Front Cell Dev Biol. 2023;11:1172895. https:\/\/doi.org\/10.3389\/fcell.2023.1172895.","journal-title":"Front Cell Dev Biol"},{"issue":"3","key":"347_CR207","doi-asserted-by":"publisher","first-page":"e190","DOI":"10.1002\/imt2.190","volume":"3","author":"W Chong","year":"2024","unstructured":"Chong W, Ren H, Chen H, Xu K, Zhu X, Liu Y, et al. Clinical features and molecular landscape of cuproptosis signature-related molecular subtype in gastric cancer. Imeta. 2024;3(3):e190. https:\/\/doi.org\/10.1002\/imt2.190.","journal-title":"Imeta"},{"key":"347_CR208","doi-asserted-by":"publisher","first-page":"940774","DOI":"10.3389\/fimmu.2022.940774","volume":"13","author":"Z Zhu","year":"2022","unstructured":"Zhu Z, Zhao Q, Song W, Weng J, Li S, Guo T, et al. A novel cuproptosis-related molecular pattern and its tumor microenvironment characterization in colorectal cancer. Front Immunol. 2022;13:940774. https:\/\/doi.org\/10.3389\/fimmu.2022.940774.","journal-title":"Front Immunol"},{"issue":"1","key":"347_CR209","doi-asserted-by":"publisher","first-page":"e41600","DOI":"10.1016\/j.heliyon.2024.e41600","volume":"11","author":"L Wang","year":"2025","unstructured":"Wang L, Li P, Gong S, Pang L, Li M, Zhang C, et al. Construction of a novel cuproptosis-related gene signature and integrative analyses in cholangiocarcinoma. Heliyon. 2025;11(1):e41600. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e41600.","journal-title":"Heliyon"},{"key":"347_CR210","doi-asserted-by":"publisher","first-page":"978865","DOI":"10.3389\/fimmu.2022.978865","volume":"13","author":"X Huang","year":"2022","unstructured":"Huang X, Zhou S, T\u00f3th J, Hajdu A. Cuproptosis-related gene index: a predictor for pancreatic cancer prognosis, immunotherapy efficacy, and chemosensitivity. Front Immunol. 2022;13:978865. https:\/\/doi.org\/10.3389\/fimmu.2022.978865.","journal-title":"Front Immunol"},{"issue":"1","key":"347_CR211","doi-asserted-by":"publisher","first-page":"6284","DOI":"10.1038\/s41598-023-33557-6","volume":"13","author":"D Li","year":"2023","unstructured":"Li D, Qu G, Ling S, Sun Y, Cui Y, Yang Y, et al. A cuproptosis-related lncRNA signature to predict prognosis and immune microenvironment of colon adenocarcinoma. Sci Rep. 2023;13(1):6284. https:\/\/doi.org\/10.1038\/s41598-023-33557-6.","journal-title":"Sci Rep"},{"key":"347_CR212","doi-asserted-by":"publisher","first-page":"1054063","DOI":"10.3389\/fonc.2022.1054063","volume":"12","author":"J Chen","year":"2022","unstructured":"Chen J, Yu X, Tong H, Tang C, Tang Z. Establishment and experimental validation of a novel cuproptosis-related gene signature for prognostic implication in cholangiocarcinoma. Front Oncol. 2022;12:1054063. https:\/\/doi.org\/10.3389\/fonc.2022.1054063.","journal-title":"Front Oncol"},{"key":"347_CR213","doi-asserted-by":"publisher","first-page":"153303382412391","DOI":"10.1177\/15330338241239139","volume":"23","author":"Q Liu","year":"2024","unstructured":"Liu Q, Zhu J, Huang Z, Zhang X, Yang J. Identification of novel cuproptosis-related genes mediating the prognosis and immune microenvironment in cholangiocarcinoma. Technol Cancer Res Treat. 2024;23:15330338241239140. https:\/\/doi.org\/10.1177\/15330338241239139.","journal-title":"Technol Cancer Res Treat"},{"key":"347_CR214","doi-asserted-by":"publisher","unstructured":"He R, Zhang H, Zhao H, Yin X, Lu J, Gu C et al. Multiomics analysis reveals cuproptosis-related signature for evaluating prognosis and immunotherapy efficacy in colorectal cancer. Cancers (Basel). 2023;15(2). https:\/\/doi.org\/10.3390\/cancers15020387.","DOI":"10.3390\/cancers15020387"},{"issue":"1","key":"347_CR215","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1186\/s12885-024-13315-1","volume":"24","author":"H Li","year":"2024","unstructured":"Li H, Chen J, Liu Z, Pan L, Lan X, Jiang L, et al. Construction of a novel copper-induced-cell-death-related gene signature for prognosis in colon cancer, with focus on KIF7. BMC Cancer. 2024;24(1):1532. https:\/\/doi.org\/10.1186\/s12885-024-13315-1.","journal-title":"BMC Cancer"},{"issue":"1","key":"347_CR216","doi-asserted-by":"publisher","first-page":"4170","DOI":"10.1038\/s41598-025-88812-9","volume":"15","author":"X Liu","year":"2025","unstructured":"Liu X, Tao P, Su H, Li Y. Machine learning-random forest model was used to construct gene signature associated with cuproptosis to predict the prognosis of gastric cancer. Sci Rep. 2025;15(1):4170. https:\/\/doi.org\/10.1038\/s41598-025-88812-9.","journal-title":"Sci Rep"},{"issue":"14","key":"347_CR217","doi-asserted-by":"publisher","first-page":"e34586","DOI":"10.1016\/j.heliyon.2024.e34586","volume":"10","author":"J Song","year":"2024","unstructured":"Song J, Xie D, Wei X, Liu B, Yao F, Ye W. A cuproptosis-related lncRNAs signature predicts prognosis and reveals pivotal interactions between immune cells in colon cancer. Heliyon. 2024;10(14):e34586. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e34586.","journal-title":"Heliyon"},{"issue":"9","key":"347_CR218","doi-asserted-by":"publisher","first-page":"6573","DOI":"10.3390\/curroncol29090517","volume":"29","author":"Y Wang","year":"2022","unstructured":"Wang Y, Huang X, Chen S, Jiang H, Rao H, Lu L, et al. In silico identification and validation of cuproptosis-related LncRNA signature as a novel prognostic model and immune function analysis in colon adenocarcinoma. Curr Oncol. 2022;29(9):6573\u201393. https:\/\/doi.org\/10.3390\/curroncol29090517.","journal-title":"Curr Oncol"},{"key":"347_CR219","doi-asserted-by":"publisher","first-page":"1200054","DOI":"10.3389\/fphar.2023.1200054","volume":"14","author":"C Li","year":"2023","unstructured":"Li C, Zhang K, Gong Y, Wu Q, Zhang Y, Dong Y, et al. Based on cuproptosis-related lncRNAs, a novel prognostic signature for colon adenocarcinoma prognosis, immunotherapy, and chemotherapy response. Front Pharmacol. 2023;14:1200054. https:\/\/doi.org\/10.3389\/fphar.2023.1200054.","journal-title":"Front Pharmacol"},{"issue":"7\u20138","key":"347_CR220","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1007\/s10495-023-01843-3","volume":"28","author":"HF Yao","year":"2023","unstructured":"Yao HF, Xu DP, Zheng JH, Xu Y, Jia QY, Zhu YH, et al. Analysis of cuproptosis-related lncRNA signature for predicting prognosis and tumor immune microenvironment in pancreatic cancer. Apoptosis. 2023;28(7\u20138):1090\u2013112. https:\/\/doi.org\/10.1007\/s10495-023-01843-3.","journal-title":"Apoptosis"},{"issue":"3","key":"347_CR221","doi-asserted-by":"publisher","first-page":"101409","DOI":"10.1016\/j.gendis.2024.101409","volume":"12","author":"K Liao","year":"2025","unstructured":"Liao K, Cheng J, Yu X, Liu Z, Zhang X, Fu Y, et al. Utilization of cuproptosis-related lncRNAs to predict the prognosis of pancreatic cancer patients and explore their roles in immune cell infiltration and prognosis evaluation. Genes Dis. 2025;12(3):101409. https:\/\/doi.org\/10.1016\/j.gendis.2024.101409.","journal-title":"Genes Dis"},{"key":"347_CR222","doi-asserted-by":"publisher","first-page":"1120827","DOI":"10.3389\/fgene.2023.1120827","volume":"14","author":"L Zhang","year":"2023","unstructured":"Zhang L, Zong L, Li W, Ning L, Zhao Y, Wang S, et al. Construction of lncRNA prognostic model related to cuproptosis in esophageal carcinoma. Front Genet. 2023;14:1120827. https:\/\/doi.org\/10.3389\/fgene.2023.1120827.","journal-title":"Front Genet"},{"key":"347_CR223","doi-asserted-by":"publisher","DOI":"10.1007\/s12013-025-01802-6","author":"J Ma","year":"2025","unstructured":"Ma J, Liu D, Li Y, Tang L, Gao X, Zhu F. A Risk prognostic signature basing on cuproptosis-related ferroptosis and immune genes for esophageal squamous cell carcinoma patients. Cell Biochem Biophys. 2025. https:\/\/doi.org\/10.1007\/s12013-025-01802-6.","journal-title":"Cell Biochem Biophys"},{"issue":"13","key":"347_CR224","doi-asserted-by":"publisher","first-page":"11647","DOI":"10.1007\/s00432-023-05005-5","volume":"149","author":"J Li","year":"2023","unstructured":"Li J, Liu J, Li J, Feng A, Nie Y, Yang Z, et al. A risk prognostic model for patients with esophageal squamous cell carcinoma basing on cuproptosis and ferroptosis. J Cancer Res Clin Oncol. 2023;149(13):11647\u201359. https:\/\/doi.org\/10.1007\/s00432-023-05005-5.","journal-title":"J Cancer Res Clin Oncol"},{"key":"347_CR225","doi-asserted-by":"publisher","first-page":"112691","DOI":"10.1016\/j.intimp.2024.112691","volume":"139","author":"Z Zhao","year":"2024","unstructured":"Zhao Z, Miao Z, Hou Y, Zhong Y, Zhang X, Fang X. A novel signature constructed by cuproptosis-related RNA methylation regulators suggesting downregulation of YTHDC2 may induce cuproptosis resistance in colorectal cancer. Int Immunopharmacol. 2024;139:112691. https:\/\/doi.org\/10.1016\/j.intimp.2024.112691.","journal-title":"Int Immunopharmacol"},{"issue":"1","key":"347_CR226","doi-asserted-by":"publisher","first-page":"17348","DOI":"10.1038\/s41598-022-22300-2","volume":"12","author":"Y Huang","year":"2022","unstructured":"Huang Y, Yin D, Wu L. Identification of cuproptosis-related subtypes and development of a prognostic signature in colorectal cancer. Sci Rep. 2022;12(1):17348. https:\/\/doi.org\/10.1038\/s41598-022-22300-2.","journal-title":"Sci Rep"},{"issue":"1","key":"347_CR227","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1186\/s13046-025-03409-4","volume":"44","author":"P Wang","year":"2025","unstructured":"Wang P, Guo W, Liu S, Li S, Li J, Ding B, et al. Novel Pt@PCN-Cu-induced cuproptosis amplifies \u03b1PD-L1 immunotherapy in pancreatic ductal adenocarcinoma through mitochondrial HK2-mediated PD-L1 upregulation. J Exp Clin Cancer Res. 2025;44(1):149. https:\/\/doi.org\/10.1186\/s13046-025-03409-4.","journal-title":"J Exp Clin Cancer Res"},{"key":"347_CR228","doi-asserted-by":"publisher","unstructured":"Kerkhove L, Geirnaert F, Rifi AL, Law KL, Guti\u00e9rrez A, Oudaert I et al. Repurposing Sulfasalazine as a Radiosensitizer in Hypoxic Human Colorectal Cancer. Cancers. 2023;15(8). https:\/\/doi.org\/10.3390\/cancers15082363.","DOI":"10.3390\/cancers15082363"},{"key":"347_CR229","doi-asserted-by":"publisher","DOI":"10.1038\/s43018-025-01037-7","author":"JM Ubellacker","year":"2025","unstructured":"Ubellacker JM, Dixon SJ. Prospects for ferroptosis therapies in cancer. Nat Cancer. 2025. https:\/\/doi.org\/10.1038\/s43018-025-01037-7.","journal-title":"Nat Cancer"},{"key":"347_CR230","doi-asserted-by":"publisher","first-page":"101018","DOI":"10.1016\/j.drup.2023.101018","volume":"72","author":"Y Wang","year":"2024","unstructured":"Wang Y, Chen Y, Zhang J, Yang Y, Fleishman JS, Wang Y, et al. Cuproptosis: a novel therapeutic target for overcoming cancer drug resistance. Drug Resist Updat. 2024;72:101018. https:\/\/doi.org\/10.1016\/j.drup.2023.101018.","journal-title":"Drug Resist Updat"},{"issue":"30","key":"347_CR231","doi-asserted-by":"publisher","first-page":"e01042","DOI":"10.1002\/advs.202501042","volume":"12","author":"ZW Chen","year":"2025","unstructured":"Chen ZW, Shan JJ, Chen M, Wu Z, Zhao YM, Zhu HX, et al. Targeting GPX4 to induce ferroptosis overcomes chemoresistance mediated by the PAX8-AS1\/GPX4 axis in intrahepatic cholangiocarcinoma. Adv Sci. 2025;12(30):e01042. https:\/\/doi.org\/10.1002\/advs.202501042.","journal-title":"Adv Sci"},{"issue":"1","key":"347_CR232","doi-asserted-by":"publisher","first-page":"e68","DOI":"10.1002\/imt2.68","volume":"2","author":"C Wu","year":"2023","unstructured":"Wu C, Tan J, Wang X, Qin C, Long W, Pan Y, et al. Pan-cancer analyses reveal molecular and clinical characteristics of cuproptosis regulators. Imeta. 2023;2(1):e68. https:\/\/doi.org\/10.1002\/imt2.68.","journal-title":"Imeta"},{"issue":"1","key":"347_CR233","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/s10238-024-01397-x","volume":"24","author":"K Wang","year":"2024","unstructured":"Wang K, Yang C, Xie J, Zhang X, Wei T, Yan Z. Long non-coding RNAs in ferroptosis and cuproptosis impact on prognosis and treatment in hepatocellular carcinoma. Clin Exp Med. 2024;24(1):135. https:\/\/doi.org\/10.1007\/s10238-024-01397-x.","journal-title":"Clin Exp Med"},{"issue":"8","key":"347_CR234","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1038\/s41580-025-00843-2","volume":"26","author":"E Mishima","year":"2025","unstructured":"Mishima E, Nakamura T, Doll S, Proneth B, Fedorova M, Pratt DA, et al. Recommendations for robust and reproducible research on ferroptosis. Nat Rev Mol Cell Biol. 2025;26(8):615\u201330. https:\/\/doi.org\/10.1038\/s41580-025-00843-2.","journal-title":"Nat Rev Mol Cell Biol"}],"container-title":["Molecular Biomedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43556-025-00347-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s43556-025-00347-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43556-025-00347-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T20:01:53Z","timestamp":1762545713000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s43556-025-00347-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,7]]},"references-count":234,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["347"],"URL":"https:\/\/doi.org\/10.1186\/s43556-025-00347-7","relation":{},"ISSN":["2662-8651"],"issn-type":[{"value":"2662-8651","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,7]]},"assertion":[{"value":"15 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The author declares no competing financial interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"101"}}